cyclosporine has been researched along with Disease Exacerbation in 268 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 34 (12.69) | 18.2507 |
| 2000's | 126 (47.01) | 29.6817 |
| 2010's | 96 (35.82) | 24.3611 |
| 2020's | 12 (4.48) | 2.80 |
| Authors | Studies |
|---|---|
| Almutlaq, H; McFeely, O; Pender, E; Storan, E; Victory, L | 1 |
| De Las Morenas-Iglesias, J; Del Estad-Cabello, A; Franco-Ruedas, C; Gonzalez-Jauregui, B; Lechon-Caballero, B; López-Herrero, F; Moruno-Rodríguez, A; Rueda-Rueda, T; Sanchez-Vicente, JL; Talego-Sancha, A | 1 |
| Gima, M; Ide, K; Ito, S; Kamei, K; Koinuma, G; Nishi, K; Ogura, M; Tamai, N | 1 |
| Benaïm, D; Béral, L; Bernier, C; Bodemer, C; Brémond-Gignac, D; Burillon, C; Cassagne, M; Cordel, N; Couret, C; Daien, V; Delcampe, A; Dereure, O; Gabison, E; Gueudry, J; Ingen-Housz-Oro, S; Kuoch, MA; Milpied, B; Muraine, M; Robert, M; Royer, G; Saunier, V; Servant, M; Tauber, M; Tétart, F; Thorel, D; Touboul, D; Vabres, B; Vasseur, R; Welfringer-Morin, A | 1 |
| Ashinoff, R; Gordon, M; Meledathu, S; Thornton, M | 1 |
| Chang, YK; Choi, BS; Chung, BH; Hong, YA; Hwang, HS; Kim, SY; Kim, Y; Kim, YS; Park, CW; Yang, CW; Yoon, HE | 1 |
| Chae, JH; Choi, J; Choi, SA; Hwang, H; Kim, H; Kim, KJ; Kim, SY; Kim, W; Lim, BC; Shim, YK | 1 |
| Cetinkaya, F; Hamuryudan, V; Hatemi, G; Melikoglu, M; Ozguler, Y; Seyahi, E; Tascilar, K; Ugurlu, S; Yazici, H | 1 |
| Kowdley, KV; Shah, RA | 1 |
| AbdelRaheem, HG; Elsantiel, HIE; Elsherif, NHK; Makkeyah, SM; Ragab, IA; Tantawy, AAG | 1 |
| Dihazi, GH; Dihazi, H; Eltoweissy, M; Jahn, O; Müller, GA; Tampe, B; Wülfrath, HS; Zeisberg, M | 1 |
| Fine, RN; Friedman, A; Gassman, JJ; Gipson, DS; Kaskel, FJ; Kopp, JB; Moxey-Mims, MM; Spino, C; Trachtman, H; Troost, JP; Walsh, L; Wang, R | 1 |
| Reamy, BV; Servey, JT; Williams, PM | 1 |
| Ardern-Jones, MR; Barbara, R; Corden, E; Hossain, PN; Martinez-Falero, BS; O'Driscoll, D; Popiela, MZ; Turnbull, AMJ | 1 |
| Balleari, E; Bernal, T; Beyne-Rauzy, O; Bordessoule, D; Calabuig, M; Cametti, G; Campelo, MD; Cheze, S; Cony-Makhoul, P; Dreyfus, F; Fenaux, P; Fensterl, J; Ferrero, D; Gaidano, G; Germing, U; Gioia, D; Götze, K; Guerci-Bresler, A; Hamel, JF; Kaivers, J; Kelaidi, C; Komrokji, R; Kotsianidis, I; Müller-Thomas, C; Pane, F; Park, S; Ramos, F; Roboz, GJ; Rose, C; Sanna, A; Santini, V; Sanz, GF; Sapena, R; Sekeres, MA; Stamatoullas, A; Steensma, DP; Thépot, S; Toma, A; Vey, N; Wattel, E | 1 |
| Baaj, ME; Doghmi, K; Eddou, H; Khalloufi, A; Mahtat, M; Mikdame, M; Moudden, MK; Sina, M; Zinebi, A | 1 |
| Bach, DQ; Badri, O; Gracey, LE; Ho, AW; Kroshinsky, D; Liu, KJ; Raff, AB; Ratushny, V; Schalock, P; St John, J; Sugai, DY | 1 |
| Chang, YL; Chou, YC; Hsu, CC; Liao, HT; Tsai, CY; Wu, TH; Yang, TH | 1 |
| Brahe, CH; Dehlendorff, C; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Johansen, JS; Junker, P; Jurik, AG; Lindegaard, H; Lottenburger, T; Stengaard-Pedersen, K; Ørnbjerg, LM; Østergaard, M | 1 |
| Chosidow, O; Colin, A; de Prost, N; Duong, TA; Fardet, L; Gaudin, O; Hotz, C; Hua, C; Ingen-Housz-Oro, S; Le Cleach, L; Lebrun-Vignes, B; Poizeau, F; Sbidian, E; Wolkenstein, P; Zehou, O | 1 |
| Boncela, J; Kryczka, J | 1 |
| Endo, Y; Fujita, Y; Fukui, S; Hara, K; Ichinose, K; Igawa, T; Ishida, M; Iwamoto, N; Kawakami, A; Kawashiri, SY; Koga, T; Kuwana, M; Nakamura, H; Nishino, A; Origuchi, T; Shimizu, T; Sumiyoshi, R; Suzuki, T; Takatani, A; Tamai, M; Tsuji, S; Umeda, M | 1 |
| Archilla, LR; Curto-Barredo, L; Giménez-Arnau, AM; Pujol, RM; Vives, GR | 1 |
| Ades, L; Arana, R; Baran-Marszak, F; Braun, T; Cereja, S; Eclache, V; Fenaux, P; Gardin, C; Kelaidi, C; Lazarian, G; Letestu, R; Lusina, D; Marceau-Renaut, A; Martin, A; Preudhomme, C; Soret, J | 1 |
| Christian, W; Newell, L; Tate, C | 1 |
| Abikhair Burgo, M; Carucci, JA; Chen, J; Doudican, N; Felsen, D; Proby, C; Roudiani, N; Santana, AL | 1 |
| Arns, W; Budde, K; Duerr, M; Eisenberger, U; Guba, M; Hauser, IA; Heller, K; Jacobi, J; Kliem, V; Lehner, F; Mühlfeld, A; Paulus, EM; Porstner, M; Reinke, P; Sommerer, C; Stahl, R; Suwelack, B; Vogt, B; Witzke, O; Wüthrich, RP; Zeier, M | 1 |
| Maj, J; Żychowska, M | 1 |
| Hayashi, K; Katayama, Y; Kobayashi, M; Machida, Y; Masumura, M; Miyashita, A; Saito, K; Toru, S; Yokote, H | 1 |
| Ashraf, S; Eddy, K; Hildebrandt, F; Hoogstraten, CA; Jobst-Schwan, T; Kolb, A; Kolvenbach, CM; Majmundar, AJ; Schmidt, JM; Schneider, R; Widmeier, E | 1 |
| Amaz, C; Claeys, MJ; Coussement, P; Dubois, P; Garcia-Dorado, D; Mewton, N; Ovize, M | 1 |
| Abrahamsen, B; Andersen, LS; Ellingsen, T; Hansen, I; Hansen, MS; Hetland, ML; Hyldstrup, L; Hørslev-Petersen, K; Jensen, TW; Junker, P; Jurik, AG; Langdahl, B; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Skjødt, H; Stengaard-Petersen, K; Svendsen, AJ; Tarp, U; Vestergaard, A; Zerahn, B; Østergaard, M | 1 |
| Akpek, EK; Smith, RA | 1 |
| Bart, PA; Bellutti Enders, F; Cavassini, M; Cellerai, C; Faouzi, M; Harari, A; Miconnet, I; Ohmiti, K; Pantaleo, G; Perreau, M; Rozot, V; Savoye, AL; Viganò, S | 1 |
| Andersen, LS; Christensen, AF; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Møller, BK; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Thorsen, J; Vestergaard, A; Østergaard, M | 1 |
| Deleuran, B; Greisen, SR; Hetland, ML; Hvid, M; Hørslev-Petersen, K; Rasmussen, TK; Stengaard-Pedersen, K | 1 |
| Hirohata, S | 1 |
| Ding, XM; Jin, ZK; Jing, X; Li, Y; Luo, ZZ; Tian, PX; Tian, XH; Wang, XZ; Xue, WJ; Zheng, J | 1 |
| Cho, B; Chung, NG; Jeong, DC; Kim, HK; Kojima, S; Kosaka, Y; Muramatsu, H; Ohara, A; Ruan, M; Takahashi, Y; Yang, W; Zhu, X; Zou, Y | 1 |
| Jung, SY | 1 |
| Cope, AP; Dahanayake, C; Lewis, CM; Ma, MH; Scott, DL; Scott, IC; Seegobin, SD | 1 |
| Tohyama, K | 1 |
| Imamura, Y | 1 |
| Alam, MF; Alrubaiy, L; Cheung, WY; Clement, C; Cohen, D; Grey, M; Hilton, M; Hutchings, H; Morgan, J; Rapport, F; Roberts, SE; Russell, D; Russell, I; Seagrove, AC; Thomas, L; Thorne, K; Watkins, A; Williams, JG | 1 |
| Enya, T; Izu, A; Miyazawa, T; Nishi, H; Okada, M; Sugimoto, K; Takemura, T | 1 |
| Chen, X; Hama, A; Hasegawa, D; Hirabayashi, S; Ishida, Y; Ito, M; Kojima, S; Manabe, A; Masunaga, A; Nakahata, T; Tsuchida, M; Watanabe, S; Yoshimi, A; Zaike, Y | 1 |
| Cope, AP; Dahanayake, C; Ma, MH; Scott, DL; Scott, IC | 1 |
| Guan, GJ; Liu, ZC; Luo, Q; Lv, XA; Xu, L | 1 |
| Dutz, JP; Kirchhof, MG; Miliszewski, MA; Papp, A; Sikora, S | 1 |
| Darrieux, L; Luce, K; Ortonne, N; Safa, G; Tisseau, L | 1 |
| Allaart, CF; de Vries-Bouwstra, JK; Han, KH; Huizinga, TW; Kerstens, PJ; Lems, WF; Markusse, IM; Schouffoer, AA; van der Lubbe, PA | 1 |
| Harendza, S; Hoxha, E; Panzer, U; Pinnschmidt, H; Stahl, RA | 1 |
| Nakao, S | 1 |
| Adán, A; Lee, RW; Llorenç, V; Mesquida, M; Molins, B; Pelegrín, L | 1 |
| Avci, BK; Cakmak, HA; Cosansu, K; Erturk, E; Ikitimur, B; Karadag, B; Ongen, Z; Seyahi, N | 1 |
| Ide, H; Ishiguro, H; Kashiwagi, E; Kawahara, T; Li, Y; Miyamoto, H; Zheng, Y | 1 |
| Duse, M; Nebbioso, M; Occasi, F; Petrarca, L; Salvatori, G; Zicari, AM | 1 |
| Barni, S; Calvani, A; Caputo, R; de Libero, C; di Grande, L; di Simone, L; Mori, F; Novembre, E; Pucci, N; Rusconi, F | 1 |
| Choudhuri, G; Kochhar, R; Ramakrishna, BS | 1 |
| Albano, L; Anglicheau, D; Di Giambattista, F; Dubois, YC; Durrbach, A; Hazzan, M; Hertig, A; Hurault deLigny, B; Lang, P; Merville, P; Moulin, B; Quéré, S; Rondeau, E; Rostaing, L; Touchard, G; Vuiblet, V | 1 |
| Ge, M; Huang, J; Huang, Z; Li, X; Nie, N; Shao, Y; Shi, J; Wang, M; Zhang, J; Zheng, Y | 1 |
| Bachta, A; Bogusławska-Walecka, R; Duda, K; Juszkiewicz, A; Kisiel, B; Kruszewski, R; Kłos, K; Płoski, R; Raczkiewicz, A; Staniszewska-Varga, J; Tłustochowicz, M; Tłustochowicz, W | 1 |
| Go, DJ; Kang, EH; Kwon, HM; Lee, EB; Lee, YJ; Park, JK; Song, YW | 1 |
| Tumian, NR; Wong, CL | 1 |
| Arita, M; Ikeda, S; Ikeo, S; Ishida, T; Ito, A; Misaki, K; Morita, M; Notohara, K; Noyama, M; Tokioka, F | 1 |
| Baig, S; Bamborschke, D; Beck, BB; Büscher, AK; Hoefele, J; Hoyer, PF; Jungraithmayr, T; Kemper, MJ; Konrad, M; Kranz, B; Lange-Sperandio, B; Melk, A; Tönshoff, B; Weber, LT; Weber, S | 1 |
| Aldredge, L; Armstrong, AW; Yamauchi, PS | 1 |
| Rudnicki, M | 1 |
| Chapman, JR; Nankivell, BJ; OʼConnell, PJ; PʼNg, CH | 1 |
| Fendler, W; Lukamowicz, J; Miklaszewska, M; Tkaczyk, M | 1 |
| Gubler, MC; Heidet, L | 1 |
| Brooks, EG; Xu, J | 1 |
| Gipson, D | 1 |
| Ali, I; Hashmi, S; Khatri, S; Lanewala, AA; Mubarak, M; Tresa, V; Yaseen, A | 1 |
| Miorin, LA; Sens, YA; Silva, FM | 1 |
| Dziankowska-Bartkowiak, B; Jurałowicz, P; Kondras, K; Kondras, M; Modzelewski, B; Torzecka, JD; Waszczykowska, E | 1 |
| Amagai, M; Nishikawa, T; Takae, Y | 1 |
| Fukuma, Y; Hatae, K; Hisano, S; Iwasaki, H; Kaku, Y; Niimi, K; Saitoh, T; Segawa, Y; Takeshita, M | 1 |
| El-Agroudy, AE; El-Baz, M; El-Dahshan, KF; Ghoneim, MA; Ismail, AM; Mahmoud, K; Shokeir, AA | 1 |
| Fuchinoue, S; Imaizumi, R; Nakajima, I; Nanmoku, K; Sakamoto, N; Teraoka, S; Tojimbara, T; Watanabe, M | 1 |
| Clevenger, CV; Dutson, LV; Feeney, YB; Koblinski, JE; Zheng, J | 1 |
| Boillot, O; Cochat, P; Dubourg, L; Hadj-Haïssa, A; Harambat, J; Lachaux, A; Liutkus, A; Ranchin, B; Rivet, C | 1 |
| Nagami, GT; Paige, NM | 1 |
| Kerzel, S; Klaus, G; Kömhoff, M; Maier, RF; Zemlin, M | 1 |
| Mimori, T; Yukawa, N | 1 |
| Yoshida, M | 1 |
| Beckebaum, S; Cicinnati, VR; Gerken, G; Klein, C; Paul, A; Saner, F; Schmitz, K; Sotiropoulos, GC; Varghese, J | 1 |
| Diomedi-Camassei, F; Emma, F; Gianviti, A; Greco, M; Kengne-Wafo, S; Massella, L; Stringini, GR; Vivarelli, M | 1 |
| Boyce, AE; Marshman, G; Mills, RA | 1 |
| Fujinaga, S; Hara, S; Murakami, H; Ohtomo, Y; Shimizu, T; Someya, T; Umino, D | 1 |
| Hamasaki, Y; Hattori, S; Honda, M; Iijima, K; Ishikura, K; Kaneko, T; Matsuyama, T; Nakanishi, K; Sasaki, S; Yata, N; Yoshikawa, N | 1 |
| Tanna, S; Ustun, C | 1 |
| Allen, JA; Jones, HR; Scala, S | 1 |
| Carrion, AP; Fuentes, GM; Garcia-Pose, A; Hijosa, MM; Melgar, AA; Meseguer, CG; Torres, MN | 1 |
| Fujii, T; Homma, S; Kurosaki, A; Miyamoto, A; Sakamoto, S; Yoshimura, K | 1 |
| Fujimoto, M; Fukuda, Y; Higashimoto, I; Kaji, K; Koreeda, Y; Kuwana, M; Takahashi, M; Yamamoto, M | 1 |
| Rao, SN | 2 |
| Andersen, LS; Ejbjerg, BJ; Ellingsen, T; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Jacobsen, S; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Pødenphant, J; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Angelico, R; Bellini, I; De Luca, L; Iaria, G; Manuelli, M; Perrone, L; Pisani, F; Sforza, D; Tisone, G | 1 |
| Honma, Y; Ichikawa, M; Kawamata, R; Koike, Y; Kono, Y; Momoi, MY; Takahashi, N; Yada, Y; Yotsumoto, S | 1 |
| Aragon, E; Chan, YH; Lau, YW; Ng, KH; Tan, PH; Yap, HK | 1 |
| Büscher, AK; Büscher, R; Dworniczak, B; Hildebrandt, F; Hoyer, PF; John, U; Kemper, M; Konrad, M; Kranz, B; Kuwertz-Bröking, E; Monnens, L; Pennekamp, P; Weber, S; Wingen, AM | 1 |
| Choi, BS; Ghee, JY; Han, DH; Ishikawa, N; Kim, J; Kim, SH; Nishijima, F; Obara, K; Piao, S; Song, JH; Yang, CW; Yoon, HE | 1 |
| Aguilera, V; Benlloch, S; Berenguer, M; de Juan, M; López-Andujar, R; Mir, J; Montalva, E; Moya, A; Pareja, E; Prieto, M; Rubin, A; San Juan, F; Yago, M | 1 |
| Dorn, C; Hellerbrand, C; Ledermann, M; Patsenker, E; Saegesser, H; Schneider, V; Stickel, F | 1 |
| Bassendine, MF; Burt, AD; Hudson, M; Kazemier, G; Kwekkeboom, J; Lindsay, AS; McPherson, S; Metselaar, HJ; Thomas, RC; Tilanus, HW; van der Laan, LJ; Zondervan, PE | 1 |
| Cai, Z; Han, X; He, J; Huang, H; Li, L; Lin, M; Luo, Y; Shi, J; Tan, Y; Xie, W; Ye, X; Zhao, Y; Zheng, Y | 1 |
| Gleeson, D; Heneghan, MA | 1 |
| Li, X; Lingyun, W; Luxi, S; Qi, Z; Qiusheng, C; Xiao, L | 1 |
| Fereshtehnejad, SM; Hooman, N; Hoseini, R; Otukesh, H; Rahimzadeh, N; Sadr, S; Tahoori, A | 1 |
| Li, B; Shao, ZY; Wang, WT; Wei, YG; Wen, TF; Xu, MQ; Yan, LN; Yang, JY; Zhao, JC | 1 |
| Asai, N; Hasegawa, Y; Hashimoto, I; Imaizumi, K; Matsuno, T; Tanaka, I; Yokoi, T | 1 |
| Goto, H; Ohkuma, K; Sada, M; Saraya, T; Takizawa, H; Tanaka, Y; Tsujimoto, N | 1 |
| Becker, JU; Bröcker, V; Gwinner, W; Haller, H; Hiss, M; Kreipe, HH; Mengel, M; Scheffner, I; Scherer, R; Schubert, V; Schwarz, A | 1 |
| Dixon, BS; Haynes, WG; Hommos, M; Sinkey, C | 1 |
| Fujita, S; Izu, A; Nishi, H; Okada, M; Sugimoto, K; Takemura, T; Takemura, Y | 1 |
| Akhter, F; Bhatti, S; Fayyaz, A; Kazi, JI; Lanewala, A; Mubarak, M; Sher, A | 1 |
| Arinuma, Y; Furukawa, H; Futami, H; Hashimoto, A; Iwata, K; Kinoshita, S; Komiya, A; Matsui, T; Moriya, H; Nakayama, H; Nogi, S; Shimada, K; Takaoka, H; Tamama, S; Tohma, S | 1 |
| Bahra, M; Boas-Knoop, S; Eurich, D; Kiessling, A; Neuhaus, P; Neuhaus, R; Neumann, UP; Puhl, G; Trautwein, C; Wasmuth, H; Yahyazadeh, A | 1 |
| Gerolymos, M; Goumenos, DS; Huang, L; Johnson, TS; Kalliakmani, P; Papasotiriou, M | 1 |
| Rolny, P; Vatn, M | 1 |
| Arnon, R; Matloff, RG; Saland, JM | 1 |
| Jaganathan, V; Sanjiv, M; Wah-Kheong, C | 1 |
| Hamasaki, Y; Honda, M; Iijima, K; Ishikura, K; Ito, S; Kaneko, T; Matsuyama, T; Nakanishi, K; Nakazato, H; Sasaki, S; Yoshikawa, N | 1 |
| Chen, Y; Wang, S; Zheng, Y; Zhu, X; Zou, Y | 1 |
| Kashiwabara, K; Ota, K | 1 |
| Everson, GT | 1 |
| Czaja, AJ | 1 |
| Duff, HJ; Kryski, AJ; Molkentin, JD; Semeniuk, LM; Severson, DL; Swirp, SL | 1 |
| Cook, DJ; Feng, J; Flechner, SM; Goel, M; Goldfarb, D; Induhara, R; Ischikawa, A; Mastroianni, B; Modlin, C; Novick, AC; Savas, K | 1 |
| Felipe, CR; Park, SI; Pestana, JO; Sampaio, EL; Silva, HT | 1 |
| Chan, HW; Lee, W; Tong, KL; Tsang, WK; Yeung, S | 1 |
| Chen, D; Gartley, CJ; Harvey, SJ; Jacobs, RM; Jefferson, B; Thorner, PS; Zheng, K | 1 |
| Kawamura, N; Kobayashi, I; Kobayashi, K; Okano, M; Sakiyama, Y; Takahashi, Y; Yamada, M | 1 |
| du Bois, RM; Gibejova, A; Kolek, V; Mrazek, F; Petrek, M; Sekerova, V; Subrtova, D; Szotkowska, J | 1 |
| Bruijn, GA; Bruyn, GA; Dijkmans, BA; Gerards, AH; Goei Thé, HS; Laan, RF; Landewé, RB; Prins, AP | 1 |
| Iwadate, H; Kanno, T; Kasukawa, R; Nishimaki, T; Sugisaki, K; Takeda, I | 1 |
| Bader, P; Bamberg, M; Einsele, H; Faul, C; Hebart, H; Kanz, L; Liebisch, P; Meisner, C; Plasswilm, L; Schäfer, HJ | 1 |
| Chen, LS; Howard, RB; Jolivalt, CG; Lai, CS; Mizisin, AP | 1 |
| Burke, E; Burkhoff, D; Edwards, N; Itescu, S; LaManca, J; Mancini, D; Marks, AR; Oz, M; Pinney, S | 1 |
| Arreghini, M; Battafarano, N; Gallazzi, M; Marchesoni, A; Panni, B; Tosi, S | 1 |
| Cattran, DC | 1 |
| Berghaus, A; Bloching, M; Born, S; Welzel, C | 1 |
| Chueh, SC; Kahan, BD | 1 |
| Fidler, SJ; Hodgson, TA; Porter, SR; Speight, PM; Weber, JN | 1 |
| Arias, M; Campistol, JM; Castro, A; García, J; Gómez, JM; Grynió, JM; Gutiérrez, JA; Morales, JM; Mota, A; Prats, D; Ruiz, JC | 1 |
| Bautista-Lopez, N; Elliott, JF; Kavanagh, KM; Liu, G; Liu, J; Nation, P; Rayner, D; Robertson, MA; Suzuki, K; Wallbank, SL; Yuan, ZN | 1 |
| Boffa, DJ; Lagman, M; Luan, F; Sharma, VK; Suthanthiran, M; Thomas, D; Yang, H | 1 |
| Goumenos, DS; Kalliakmani, P; Sotsiou, F; Tsakas, S; Vlachojannis, JG | 1 |
| Darmawan, J; Nuralim, H; Rasker, JJ | 1 |
| Baczkowski, AJ; Hammad, AQ; Newstead, CG; Owens, G; Paraoan, M; Stoves, J | 1 |
| Centeno, J; Crovetto, M; Solano, D | 1 |
| Akalin, E; Ames, S; Bromberg, JS; Daly, L; Murphy, B; Sehgal, V | 1 |
| Natarajan, S; Sinha, A; Velangi, S | 1 |
| Baelde, HJ; Bruijn, JA; de Heer, E; Eikmans, M; Ijpelaar, DH | 1 |
| Pereleux, AA; Rasquin, FA | 1 |
| Arias, M; Campistol, JM; García, J; Gómez, JM; Grinyó, JM; Gutiérrez, JA; Henriques, AC; Morales, JM; Mota, A; Pinto, JR; Prats, D; Ruiz, JC | 1 |
| Konishi, T; Nishizawa, T; Yoshida, S; Yoshida, Y | 1 |
| Böhm, M; Ecker, KW; Giese, T; Jüngling, B; Kindermann, I; Moser, C; Püschel, W; Schäfers, HJ; Stallmach, A; Zeuzem, S | 1 |
| Goodfield, MJ; Rose, RF | 1 |
| Alimohamadi, SM; Hagh-Azali, S; Malekzadeh, R; Mohamadnejad, M; Nasseri-Moghaddam, S; Rakhshani, N; Sedaghat, M; Tavangar, SM | 1 |
| Ahmed, M; Foster, CS; Kiss, S; Letko, E | 1 |
| Bernstein, M; Blaney, S; Chen, Z; Fisher, PG; Freeman, C; Friedman, H; Greenberg, ML; Hershon, L; Korones, DN; Kretschmar, C; Zhou, T | 1 |
| Ichimaru, N; Imamura, R; Matsumiya, K; Moriyama, T; Namba, Y; Nonomura, N; Okuyama, A; Shi, Y; Takahara, S; Toki, K | 1 |
| Abbas, S; Al Aly, Z; Bastani, B; Diallo, O; Hauptman, PJ; Moore, E | 1 |
| El-Basuony, F; El-Husseini, A; Hassan, N; Hassan, R; Mahmoud, I; Sabry, A; Sayed-Ahmad, N; Sheashaa, H; Sobh, M; Taha, N | 1 |
| Ito, E; Kudo, M; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K; Waga, S | 1 |
| Batra, M; Fierlbeck, G; Günaydin, I; Kötter, I; Melms, A; Stübiger, N; Vonthein, R | 1 |
| Morales, JM | 1 |
| Agura, E; Al-Ali, H; Bruno, B; Chauncey, T; Cordonnier, C; Gratwohl, A; Greinix, H; Hegenbart, U; Lange, T; Maloney, D; Maris, MB; Maziarz, RT; McSweeney, P; Niederwieser, D; Petersen, F; Rio, B; Sandmaier, BM; Shizuru, JA; Storb, R; Storer, B | 1 |
| Bruch, D; Kittur, DS; Kittur, S; Ondocin, P; Wilasrusmee, C; Wilasrusmee, S; Yusupov, I | 1 |
| Ando, M; Fukami, T; Kumamoto, T; Matsuno, O; Miyazaki, E; Muramatsu, T; Nureki, S; Tsuda, T; Ueno, T | 1 |
| Genth, E; Hunzelmann, N; Kaufmann, J; Krieg, T | 1 |
| Davis, GL | 1 |
| Chim, CS; Ooi, GC | 1 |
| Angelico, M; Anselmo, A; Baiocchi, L; Cardillo, A; Lionetti, R; Manzia, TM; Orlando, G; Palmieri, G; Tisone, G; Toti, L | 1 |
| Aguilera, V; Benlloch, S; Berenguer, J; Berenguer, M; Prieto, M; Rayón, JM; San Juan, F | 1 |
| Gordon, KB; Ruderman, EM | 1 |
| Dosanjh, A | 1 |
| Lesiak, A; McCauliffe, DP; Salamon, M; Sysa-Jedrzejowska, A; Wozniacka, A | 1 |
| Broliden, PA; Dahl, IM; Hast, R; Hellstrom-Lindberg, E; Johansson, B; Juvonen, E; Kjeldsen, L; Oberg, G; Porwit-MacDonald, A; Sjoo, M; Tangen, JM; Uggla, B | 1 |
| Caggiari, L; De Re, V; De Vita, S; Fabris, M; Ferraccioli, G; Franzolini, N; Gasparotto, D; Marzotto, A; Quartuccio, L; Scott, CA | 1 |
| Nunez, O; Scheinberg, P; Wu, C; Young, NS | 1 |
| Amoura, Z; Bader-Meunier, B; Delfraissy, JF; Godeau, B; Goujard, C; Harmouche, H; Khellaf, M; Lambotte, O; Manceron, V; Piette, JC | 1 |
| Chapman, JR; Nankivell, BJ | 1 |
| Kobayashi, E; Murakami, T; Ohsawa, I; Uemoto, S | 2 |
| Kotyla, PJ; Kucharz, EJ; Lewicki, M; Sliwińska-Kotyla, B | 1 |
| Canales, M; Hertz, M; Ibrahim, HN; Ishani, A; Savik, K; Spong, R; Youssef, P | 1 |
| Beijnen, JH; Binlich, F; Garrigue, JS; Huitema, AD; Lallemand, F; Lambert, G; Nol, A; Nuijen, B; Schellens, JH; Thijssen, B; Veltkamp, SA | 1 |
| Chalermsanyakorn, P; Changsirikulchai, S; Lothuvachai, T; Sumethkul, V | 1 |
| Akool, el-S; Doller, A; Eberhardt, W; Gutwein, P; Kurowski, C; Müller, R; Pfeilschifter, J | 1 |
| Hirohata, S; Ishii, M; Katada, Y; Kosaka, H; Mima, T; Muramoto, Y; Ohshima, S; Saeki, Y | 1 |
| Flynn, JT; Schoeneman, M; Shatat, IF; Woroniecki, RP | 1 |
| Baumann, I; Bergsträsser, E; Fischer, A; Führer, M; Göbel, U; Gross-Wieltsch, U; Klingebiel, T; Niemeyer, C; Nöllke, P; Sykora, KW; van den Heuvel-Eibrink, MM; Yoshimi, A | 1 |
| Saito, E; Suwa, A; Suzuki, Y; Wakabayashi, T | 2 |
| Basile, DP; Donohoe, DL; James, L; Lund, H; Mattson, DL; Spurgeon-Pechman, KR | 1 |
| Cai, SR; Zhang, SZ; Zheng, S | 1 |
| Gu, M; Liu, M; Lv, Q; Xu, D; Yin, C; Zhang, W; Zhang, WY | 1 |
| Andersen, LS; Ellingsen, T; Hansen, GV; Hansen, I; Hetland, ML; Hørslev-Petersen, K; Junker, P; Jurik, AG; Lauridsen, UB; Lindegaard, H; Lottenburger, T; Pedersen, JK; Skjødt, H; Stengaard-Pedersen, K; Svendsen, A; Tarp, U; Vestergaard, A; Østergaard, M | 1 |
| Dalal, L | 1 |
| Bacigalupo, A; Del Vecchio, GC; Dufour, C; Iori, AP; Locasciulli, A; Longoni, D; Quarello, P; Ramenghi, U; Saracco, P; Svahn, J; Varotto, S; Zecca, M | 1 |
| Jensen, GS; Trotter, JF; Wiseman, A | 1 |
| DuBay, D; Levy, GA; Lilly, L; Qiu, KG; Smith, RJ; Therapondos, G | 1 |
| Duncan, FJ; Kusewitt, DF; Oberyszyn, TM; Thomas-Ahner, JM; VanBuskirk, AM; Wulff, BC | 1 |
| Bang, BK; Chang, YS; Kim, YS; Koh, YB; Yang, CW; Yoon, SA; Yoon, YS | 1 |
| Breedveld, FC | 1 |
| Chevillard, S; Dorval, T; Lokiec, F; Oudard, S; Pouillart, P; Poupon, MF | 1 |
| Bensi, L; Emilia, G; Messora, C | 1 |
| Loh, E; Schoen, FJ; Winters, GL | 1 |
| Baskerville, J; Issa, M; Weinshenker, BG | 1 |
| Della Casa-Alberighi, O; Fantini, F; Ferraccioli, G; Magaro, M; Marcolongo, R; Marubini, E; Oriente, P; Pasero, G; Pipitone, V; Portioli, I; Priolo, F; Tirri, G; Trotta, F | 1 |
| Schnaper, HW | 1 |
| Emery, P; van de Putte, LB | 1 |
| Cutolo, M; Della Casa-Alberighi, O; Fantini, F; Ferraccioli, GF; Marubini, E; Mathieu, A; Pasero, G; Priolo, F | 1 |
| Kwong, YL; Wong, KF | 1 |
| Elkhalifa, MY; King, JA; Latour, LF | 1 |
| Afeltra, A; Amoroso, A; Bonomo, L; Caccavo, D; Ferri, GM; Laganà, B; Mitterhofer, AP | 1 |
| Alarcón, GS | 1 |
| Boneschi, V; Brambilla, L; Ferrucci, S; Finzi, AF; Fossati, S | 1 |
| Agostini, HT; Baumhefner, RW; Ryschkewitsch, CF; Stoner, GL; Tourtellotte, WW | 1 |
| Alheit, B; Bardin, PG; Joubert, JR; van Schalkwyk, EM; Wyser, CP | 1 |
| Alekseeva, EI; Chistiakova, EG; Isaeva, KB; Khudoleeva, EIu; Shakhbazian, IE | 1 |
| Chia, D; Hirata, M; Katznelson, S; Kobashigawa, JA; Ozawa, M; Terasaki, PI; Wang, XM; Zhong, HP | 1 |
| de Almeida, OP; Line, SR; Lopes, MA; Spolidório, LC | 1 |
| Battistel, B; Beltrandi, E; Boiardi, L; Casadei-Maldini, M; Cremonesi, T; Macchioni, P; Mancini, R; Salvarani, C | 1 |
| Førre, O; Geidel, H; Hafström, I; Hannonen, P; Kaltwasser, JP; Kurki, P; Kvien, TK; Laasonen, L; Leirisalo-Repo, M; Manger, B; Markert, ER; Prestele, H; Wollheim, FA; Zeidler, HK | 1 |
| de Courten, C; Herbort, CP | 1 |
| Favre, H; Lemoine, R; Miescher, PA; Tamagnini, P | 1 |
| Antunes, NL; Boulad, F; George, D; Lis, E; Small, TN | 1 |
| Lärfars, G; Samuelsson, J | 1 |
| Büki, A; Okonkwo, DO; Povlishock, JT | 1 |
| Julian, BA; Nowack, R; Schiele, J; van der Woude, FJ | 1 |
| Elpern, S; McFarland, H; Roca, CA; Rubinow, DR; Su, TP | 1 |
| Furukawa, Y; Hara, M; Hwang, MW; Iwasaki, A; Matsumori, A; Okada, M; Ono, K; Sasayama, S | 1 |
| Broadbent, V; Ceci, A; Grois, N; Jakobson, A; Ladisch, S; Minkov, M | 1 |
| Nakamura, K; Ohmori, K; Tamura, T | 1 |
| Aküyrek, LM; Backman, U; Fellström, B; Jonsson, C; Larsson, E; Tufveson, G; Wahlberg, J | 1 |
| Drosos, AA; Katsaraki, A; Voulgari, PV; Zikou, AK | 1 |
| De Windt, LJ; Kimball, TR; Lim, HW; Molkentin, JD; Steinberg, L; Taigen, T; Witt, SA | 1 |
| Hayashida, W; Kihara, Y; Sasayama, S; Yasaka, A | 1 |
| Fiejka, E; Małdyk, J; Mizerska-Wasiak, M; Roszkowska-Blaim, M; Weglarska, J | 1 |
| Anderson, B; Buller, RE; Skilling, JS; Sood, AK; Sorosky, JI; Squatrito, RC | 1 |
| Sheiner, PA | 1 |
| Merkel, F; Weber, M | 1 |
| Kliukvina, NG; Nasonov, EL; Nasonova, VA; Shekshina, SV | 1 |
| Christians, U; Gummert, JF; Hausen, B; Hayase, M; Honda, Y; Ikonen, TS; Kobayase, Y; Morris, RE; Serkova, N; Yock, PG | 1 |
| Bang, BK; Kim, SY; Kim, YS; Koh, YB; Moon, IS; Park, JH; Yang, CW | 1 |
| Ebisui, C; Fukunishi, T; Hanafusa, T; Ichikawa, Y; Kyo, M; Nagano, S; Nojima, M; Tsubakihara, Y; Yazawa, K | 1 |
| Bonser, RS; Lewis, ME; Llewellyn-Jones, CG; Revell, MP; Wilson, IC | 1 |
| Mathieu, A; Passiu, G; Pittau, E | 1 |
| Kurosaka, D; Ozawa, Y; Tajima, N; Yokoyama, T | 1 |
| Fukumura, A; Karasawa, H; Kawabata, H; Kim, CG; Masaki, Y; Ogawa, N; Okada, J; Simoyama, K; Sugai, S; Wano, Y | 1 |
| Baldwin, W; Chen, W; Hess, AD; Hruban, R; Miura, Y; Qian, Z; Sommer, M; Thoburn, CJ | 1 |
| Flammer, J; Haefliger, IO; Messerli, J; Moser, HR; Prünte, C; Vonmoos, F | 1 |
| Blume, KG; Chauncey, T; Feinstein, L; Flowers, C; Georges, G; Kiem, HP; Little, MT; Maloney, D; Maris, M; McSweeney, PA; Nash, RA; Niederwieser, D; Radich, J; Sandmaier, B; Shizuru, J; Storb, R; Woolfrey, A; Zaucha, JM | 1 |
| Inoue , K; Kawahito, Y; Sano, H; Yoshikawa, T | 1 |
| Han, SB; Jeon, YJ; Kim, HM; Kim, YK; Park, SH; Yang, KH | 1 |
| Green, J; Sinclair, RD | 1 |
| Chalopin, JM; Dubiez, A; Ducloux, D; Justrabo, E; Motte, G | 1 |
| Ebina, M; Hagiwara, K; Koinuma, D; Kondo, T; Miki, M; Nukiwa, T; Taguchi, Y; Tahara, M | 1 |
| Arias, M; Campistol, JM; Castro, A; García, J; Grinyo, JM; Gutiérrez, A; Morales, JM; Mota, A; Pinto, JR; Prats, D; Ruiz, JC | 1 |
| Chang, HK; Park, W; Ryu, DS | 1 |
| Itoh, M; Shimada, H; Tohyama, K; Yago, K | 1 |
| Ishikawa, T; Tohyama, K | 1 |
| Inase, N; Miyake, S; Miyasaka, N; Miyazaki, Y; Ohtani, Y; Sawada, M; Takano, S; Yoshizawa, Y | 1 |
40 review(s) available for cyclosporine and Disease Exacerbation
| Article | Year |
|---|---|
Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review.
Topics: Autoantibodies; Child, Preschool; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Female; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Rituximab | 2022 |
Ocular sequelae of epidermal necrolysis: French national audit of practices, literature review and proposed management.
Topics: Adrenal Cortex Hormones; Cyclosporine; Disease Progression; Humans; Lubricant Eye Drops; Stevens-Johnson Syndrome | 2023 |
Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Case Report and Literature Review.
Topics: Adrenal Cortex Hormones; Cyclosporine; Disease Progression; Etanercept; Humans; Male; Middle Aged; Stevens-Johnson Syndrome | 2023 |
Current and potential treatments for primary biliary cholangitis.
Topics: Benzothiazoles; Bezafibrate; Bile Acids and Salts; Budesonide; Case-Control Studies; Chenodeoxycholic Acid; Cholagogues and Choleretics; Clinical Trials as Topic; Cyclosporine; Disease Progression; Glucocorticoids; Homeostasis; Humans; Immunologic Factors; Immunosuppressive Agents; Isoxazoles; Liver Cirrhosis, Biliary; Liver Transplantation; Peroxisome Proliferator-Activated Receptors; Receptors, Cytoplasmic and Nuclear; Rituximab; Treatment Outcome; United States; United States Food and Drug Administration; Ursodeoxycholic Acid | 2020 |
Henoch-Schönlein Purpura (IgA Vasculitis): Rapid Evidence Review.
Topics: Acetaminophen; Adrenal Cortex Hormones; Adult; Analgesics, Non-Narcotic; Anti-Inflammatory Agents, Non-Steroidal; Arthralgia; Child; Cyclosporine; Disease Progression; Glomerulonephritis; Humans; IgA Vasculitis; Immunosuppressive Agents; Mycophenolic Acid; Nephrology; Recurrence; Referral and Consultation; Remission, Spontaneous; Urinalysis | 2020 |
Cell Migration Related to MDR-Another Impediment to Effective Chemotherapy?
Topics: Antibodies, Monoclonal; Antineoplastic Agents; ATP-Binding Cassette Transporters; Cancer-Associated Fibroblasts; Cell Movement; Cyclosporine; Disease Progression; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Neoplasm Proteins; Neoplasms; Treatment Failure; Verapamil | 2018 |
Onset and progression of diabetes in kidney transplant patients receiving everolimus or cyclosporine therapy: an analysis of two randomized, multicenter trials.
Topics: Aged; Cyclosporine; Diabetes Mellitus; Disease Progression; Everolimus; Female; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2018 |
Current treatment strategies for age-related ocular conditions.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Disease Progression; Dry Eye Syndromes; Glaucoma; Glycated Hemoglobin; Humans; Macular Degeneration; Medication Adherence; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A | 2013 |
[Recent aspects of Neuro-Behcet's disease].
Topics: Antibodies, Monoclonal; Behcet Syndrome; Chronic Disease; Cyclosporine; Disease Progression; Humans; Infliximab; Interleukin-6 | 2013 |
[Myelodysplastic syndromes: treatment strategy up-to-date].
Topics: Antilymphocyte Serum; Azacitidine; Benzoates; Cyclosporine; Cytarabine; Deferasirox; Disease Progression; Drug Discovery; Drug Therapy, Combination; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Idarubicin; Immunosuppressive Agents; Iron Chelating Agents; Lenalidomide; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; Quality of Life; Risk Assessment; Thalidomide; Triazoles | 2014 |
[Hemophagocytic lymphohistiocytosis].
Topics: Antibodies, Monoclonal, Murine-Derived; Antilymphocyte Serum; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cord Blood Stem Cell Transplantation; Cyclophosphamide; Cyclosporine; Disease Progression; Doxorubicin; Drug Therapy, Combination; Etoposide; Hematopoietic Stem Cell Transplantation; Humans; Lymphohistiocytosis, Hemophagocytic; Methotrexate; Multiple Organ Failure; Prednisolone; Prednisone; Rituximab; Severity of Illness Index; Transplantation Conditioning; Vidarabine; Vincristine | 2014 |
[Recent progress in the management of aplastic anemia].
Topics: Acute Disease; Anemia, Aplastic; Antilymphocyte Serum; Benzoates; Chronic Disease; Cyclosporine; Disease Progression; Hematopoiesis; Humans; Hydrazines; Immunosuppressive Agents; Pyrazoles | 2014 |
Natural history of first episode of acute severe colitis.
Topics: Acute Disease; Adrenal Cortex Hormones; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Diagnosis, Differential; Disease Progression; Gastrointestinal Agents; Humans; Immunosuppressive Agents; Infliximab; Risk Factors | 2014 |
Pregnancy-related hemophagocytic lymphohistiocytosis associated with cytomegalovirus infection: A diagnostic and therapeutic challenge.
Topics: Adult; Cesarean Section; Combined Modality Therapy; Cyclosporine; Cytomegalovirus Infections; Dexamethasone; Disease Progression; Drug Resistance, Multiple; Drug Therapy, Combination; Fatal Outcome; Female; Humans; Infusions, Intravenous; Lymphohistiocytosis, Hemophagocytic; Multiple Organ Failure; Plasma Exchange; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; Severity of Illness Index | 2015 |
Managing Patients With Psoriasis in the Busy Clinic: Practical Tips for Health Care Practitioners.
Topics: Acitretin; Anti-Inflammatory Agents, Non-Steroidal; Biological Products; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Insurance, Health, Reimbursement; Keratolytic Agents; Medication Adherence; Methotrexate; Psoriasis; Symptom Flare Up; Thalidomide | 2016 |
FSGS Recurrence in Adults after Renal Transplantation.
Topics: Adult; Age Factors; Animals; Child; Cyclosporine; Disease Models, Animal; Disease Progression; Glomerulosclerosis, Focal Segmental; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Mutation; Podocytes; Postoperative Complications; Rats; Recurrence; Registries; Renin-Angiotensin System; Risk Factors; Rituximab | 2016 |
Giant Cell Myocarditis: A Brief Review.
Topics: Animals; Cyclosporine; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Early Diagnosis; Giant Cell Tumors; Heart; Heart Neoplasms; Humans; Immunosuppressive Agents; Lymphocyte Activation; Myocarditis; Myocardium; Prognosis; Severity of Illness Index | 2016 |
[Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Cysteine; Disease Progression; Drug Therapy, Combination; Gold Sodium Thiomalate; Humans; Isoxazoles; Leflunomide; Methotrexate; Penicillamine; Radiography; Randomized Controlled Trials as Topic; Sulfasalazine; Tacrolimus | 2009 |
[Strategy of immunosuppressants usage for subjects with loss of renal function and infection control on RPGN].
Topics: Autoantibodies; Azathioprine; Churg-Strauss Syndrome; Contraindications; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Interactions; Glomerular Basement Membrane; Glomerulonephritis; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Opportunistic Infections; Pulse Therapy, Drug; Severity of Illness Index | 2009 |
Cyclosporine in patients with severe steroid refractory ulcerative colitis in the era of infliximab. Review article.
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents; Antibodies, Monoclonal; Colectomy; Colitis, Ulcerative; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Infliximab; Treatment Failure; Treatment Outcome | 2013 |
The kidney in pediatric liver transplantation: an updated perspective.
Topics: Child; Child, Preschool; Creatinine; Cyclosporine; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Infant; Kidney; Liver Transplantation; Male; Postoperative Period; Renal Insufficiency, Chronic; Risk; Risk Factors | 2012 |
Impact of immunosuppressive therapy on recurrence of hepatitis C.
Topics: Cyclosporine; Disease Progression; Glucocorticoids; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Muromonab-CD3; Mycophenolic Acid; Receptors, Interleukin-2; Recurrence; Risk Assessment; Sirolimus; Tacrolimus | 2002 |
Treatment strategies in autoimmune hepatitis.
Topics: Azathioprine; Budesonide; Clinical Trials as Topic; Cyclosporine; Disease Progression; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Mycophenolic Acid; Prednisolone; Tacrolimus; Treatment Outcome; Ursodeoxycholic Acid | 2002 |
Mycophenolate mofetil and cyclosporine therapy in membranous nephropathy.
Topics: Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; Randomized Controlled Trials as Topic; Risk Factors | 2003 |
The use of extracellular matrix probes and extracellular matrix-related probes for assessing diagnosis and prognosis in renal diseases.
Topics: Biomarkers; Chronic Disease; Cyclosporine; Cytokines; Disease Progression; Drug-Related Side Effects and Adverse Reactions; Extracellular Matrix; Gene Expression; Graft Rejection; Humans; Kidney Diseases; Metalloproteases; Predictive Value of Tests; Tissue Inhibitor of Metalloproteinases | 2004 |
Immunosuppressive treatment and progression of histologic lesions in kidney allografts.
Topics: Animals; Cyclosporine; Disease Progression; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Risk Factors; Sirolimus; Tacrolimus; Transplantation, Homologous | 2005 |
[The clinical spectrum of dermatomyositis].
Topics: Adult; Age Factors; Azathioprine; Biopsy; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporine; Dermatologic Agents; Dermatomyositis; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Muscles; Mycophenolic Acid; Paraneoplastic Syndromes; Plasmapheresis; Prognosis; Sex Factors; Time Factors | 2005 |
The treatment of psoriasis and psoriatic arthritis: an interdisciplinary approach.
Topics: Adalimumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Arthritis, Psoriatic; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Etanercept; Etretinate; Humans; Immunoglobulin G; Immunosuppressive Agents; Infliximab; Keratolytic Agents; Methotrexate; Psoriasis; Receptors, Tumor Necrosis Factor; Tumor Necrosis Factor-alpha | 2006 |
Nephrotoxicity of ciclosporin A: short-term gain, long-term pain?
Topics: Acute Disease; Chronic Disease; Clinical Trials as Topic; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Graft Rejection; Graft vs Host Disease; Humans; Immunosuppressive Agents; Kidney Diseases; Postoperative Complications; Sirolimus; Tacrolimus | 2006 |
[Risk of atherosclerosis development in patients with systemic lupus erythematosus].
Topics: Adrenal Cortex Hormones; Arteriosclerosis; Autoantibodies; Azathioprine; Blood Coagulation Disorders; Cardiovascular Diseases; Causality; Comorbidity; Cyclosporine; Disease Progression; Female; Humans; Lupus Erythematosus, Systemic; Myocardial Infarction; Risk Factors | 2005 |
[Inhibition of radiographic progression in rheumatoid arthritis by anti-rheumatic drugs (DMARDs)].
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Clinical Trials as Topic; Cyclosporine; Disease Progression; Humans; Isoxazoles; Joints; Leflunomide; Methotrexate; Radiography; Remission Induction; Sulfasalazine | 2007 |
[Pathologic condition of osteoporosis in rheumatoid arthritis].
Topics: Arthritis, Rheumatoid; Bone Remodeling; Bone Resorption; Cell Differentiation; Cyclosporine; Disease Progression; Glucocorticoids; Humans; Menopause; Methotrexate; Osteoclasts; Osteoporosis; RANK Ligand; Tumor Necrosis Factor-alpha | 2007 |
Medical treatment of ulcerative colitis.
Topics: Adrenal Cortex Hormones; Antibodies, Monoclonal; Colitis; Colitis, Ulcerative; Cyclosporine; Disease Progression; Humans; Immunologic Factors; Infliximab; Recurrence; Remission Induction | 2007 |
Meta-analysis of the placebo-treated groups in clinical trials of progressive MS.
Topics: Autoimmune Diseases; Azathioprine; Brain Stem; Clinical Trials, Phase III as Topic; Cyclosporine; Disease Progression; Double-Blind Method; Female; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Multiple Sclerosis; Placebos; Plasma Exchange; Pyramidal Tracts; Randomized Controlled Trials as Topic; Severity of Illness Index; Treatment Failure | 1996 |
Primary nephrotic syndrome of childhood.
Topics: Child; Cyclosporine; Disease Progression; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Kidney; Nephrotic Syndrome; Prognosis | 1996 |
New perspectives on controlling progression of severe rheumatoid arthritis--a summary of the potential role of cyclosporin.
Topics: Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans | 1996 |
Rapid progression of acquired amegakaryocytic thrombocytopenia to aplastic anemia.
Topics: Anemia, Aplastic; Bone Marrow; Cyclosporine; Disease Progression; Erythrocyte Transfusion; Fatal Outcome; Humans; Male; Megakaryocytes; Middle Aged; Platelet Transfusion; Purpura, Thrombocytopenic | 1997 |
Treatment of immunoglobulin A nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Cyclosporine; Disease Progression; Fish Oils; Glomerulonephritis, IGA; Humans; Hypertension; Immunosuppressive Agents; Mycophenolic Acid; Proteinuria; Steroids; Treatment Outcome | 1999 |
[New fields of cyclosporin A (sandimmun) application in rheumatology: treatment of systemic lupus erythematosus].
Topics: B-Lymphocytes; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Interleukin-12; Interleukin-6; Lupus Erythematosus, Systemic; Macrophages; Rheumatology; Treatment Outcome | 2000 |
Nonmyeloablative hematopoietic cell transplantation. Replacing high-dose cytotoxic therapy by the graft-versus-tumor effect.
Topics: Adult; Animals; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclosporine; Disease Progression; Dogs; Forecasting; Graft Enhancement, Immunologic; Graft Survival; Graft vs Host Disease; Graft vs Tumor Effect; Hematopoietic Stem Cell Transplantation; Histocompatibility; Humans; Immunosuppressive Agents; Lymphocyte Transfusion; Methotrexate; Middle Aged; Mycophenolic Acid; Neoplasms; Prednisone; Radiation Chimera; T-Lymphocytes, Cytotoxic; Tissue Donors; Transplantation Conditioning; Transplantation, Homologous; Treatment Outcome; Vidarabine; Whole-Body Irradiation | 2001 |
46 trial(s) available for cyclosporine and Disease Exacerbation
| Article | Year |
|---|---|
Proteinuria Reduction and Kidney Survival in Focal Segmental Glomerulosclerosis.
Topics: Adolescent; Child; Cohort Studies; Creatinine; Cyclosporine; Dexamethasone; Disease Progression; Female; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Male; Mortality; Mycophenolic Acid; Prognosis; Proportional Hazards Models; Proteinuria; Remission Induction; Tissue Survival; Treatment Outcome; Young Adult | 2021 |
Clinical effects of cyclosporine in acute anterior myocardial infarction complicated by heart failure: A subgroup analysis of the CIRCUS Trial.
Topics: Anterior Wall Myocardial Infarction; Cardiotonic Agents; Cyclosporine; Disease Progression; Double-Blind Method; Female; Heart Failure; Humans; Logistic Models; Male; Middle Aged; Percutaneous Coronary Intervention; Prospective Studies | 2019 |
Periarticular and generalised bone loss in patients with early rheumatoid arthritis: influence of alendronate and intra-articular glucocorticoid treatment. Post hoc analyses from the CIMESTRA trial.
Topics: Adult; Aged; Alendronate; Antirheumatic Agents; Arthritis, Rheumatoid; Betamethasone; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Bone Resorption; Cyclosporine; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Injections, Intra-Articular; Lumbar Vertebrae; Male; Methotrexate; Middle Aged; Radiography; Treatment Outcome; Young Adult | 2014 |
Upregulated baseline plasma CCL19 and CCR7 cell-surface expression on monocytes in early rheumatoid arthritis normalized during treatment and CCL19 correlated with radiographic progression.
Topics: Adult; Aged; Antibodies, Anti-Idiotypic; Antirheumatic Agents; Arthritis, Rheumatoid; C-Reactive Protein; CD4-Positive T-Lymphocytes; Chemokine CCL19; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Longitudinal Studies; Male; Methotrexate; Middle Aged; Monocytes; Peptides, Cyclic; Radiography; Receptors, CCR7; Severity of Illness Index; Treatment Outcome; Up-Regulation | 2014 |
Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis.
Topics: Aged; Antibodies, Anti-Idiotypic; Arthritis, Rheumatoid; Betamethasone; Biomarkers; Case-Control Studies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Interleukins; Longitudinal Studies; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Programmed Cell Death 1 Receptor; Radiography; Rheumatoid Factor; Severity of Illness Index | 2014 |
Increased intracellular adenosine triphosphate level as an index to predict acute rejection in kidney transplant recipients.
Topics: Acute Disease; Adenosine Triphosphate; Adult; CD4-Positive T-Lymphocytes; Cell Count; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Rejection; Humans; Immunosuppressive Agents; Intracellular Space; Kidney Transplantation; Male; Middle Aged; Predictive Value of Tests; Prognosis; Prospective Studies; Tacrolimus; Transplantation | 2014 |
ACPA-positive and ACPA-negative rheumatoid arthritis differ in their requirements for combination DMARDs and corticosteroids: secondary analysis of a randomized controlled trial.
Topics: Adrenal Cortex Hormones; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Autoantigens; Cyclosporine; Disease Progression; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisolone; Quality of Life | 2014 |
Randomised controlled trial. Comparison Of iNfliximab and ciclosporin in STeroid Resistant Ulcerative Colitis: Trial design and protocol (CONSTRUCT).
Topics: Adrenal Cortex Hormones; Colectomy; Colitis, Ulcerative; Cost-Benefit Analysis; Cyclosporine; Disease Progression; Drug Costs; Drug Resistance; Humans; Immunosuppressive Agents; Infliximab; Quality of Life; Quality-Adjusted Life Years; United Kingdom | 2014 |
Cyclosporine A combined with medium/low dose prednisone in progressive IgA nephropathy.
Topics: Adult; Biomarkers; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Humans; Male; Prednisone; Treatment Outcome | 2014 |
Feasibility of tailored treatment based on risk stratification in patients with early rheumatoid arthritis.
Topics: Adult; Aged; Antibodies, Monoclonal; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Feasibility Studies; Female; Humans; Infliximab; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Remission Induction; Risk Factors; Sulfasalazine; Time Factors; Treatment Outcome | 2014 |
Tacrolimus vs. cyclosporine eyedrops in severe cyclosporine-resistant vernal keratoconjunctivitis: A randomized, comparative, double-blind, crossover study.
Topics: Child; Conjunctivitis, Allergic; Creatinine; Cross-Over Studies; Cyclosporine; Disease Progression; Double-Blind Method; Drug Resistance; Eye; Female; Humans; Male; Ophthalmic Solutions; Quality of Life; Tacrolimus | 2015 |
Fibrosis progression according to epithelial-mesenchymal transition profile: a randomized trial of everolimus versus CsA.
Topics: Adolescent; Adult; Aged; Biopsy; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Epithelial-Mesenchymal Transition; Everolimus; Female; Fibrosis; Graft Survival; Humans; Immunosuppression Therapy; Inflammation; Kidney; Kidney Transplantation; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Risk Factors; Treatment Outcome | 2015 |
Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome.
Topics: Administration, Oral; Biopsy; Child; Child, Preschool; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Infusions, Intravenous; Japan; Male; Methylprednisolone; Nephrotic Syndrome; Prednisolone; Prospective Studies; Randomized Controlled Trials as Topic; Remission Induction; Steroids; Time Factors; Treatment Outcome | 2009 |
Topical cyclosporine 0.05% for the prevention of dry eye disease progression.
Topics: Administration, Topical; Adult; Cell Count; Cyclosporine; Disease Progression; Dry Eye Syndromes; Female; Follow-Up Studies; Goblet Cells; Humans; Immunosuppressive Agents; Male; Middle Aged; Ophthalmic Solutions; Prognosis; Prospective Studies | 2010 |
Radiographic progression and remission rates in early rheumatoid arthritis - MRI bone oedema and anti-CCP predicted radiographic progression in the 5-year extension of the double-blind randomised CIMESTRA trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Biomarkers; Bone Marrow Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Epidemiologic Methods; Female; Humans; Immunosuppressive Agents; Magnetic Resonance Imaging; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prognosis; Radiography; Remission Induction | 2010 |
Good outcomes with mycophenolate-cyclosporine-based induction protocol in children with severe proliferative lupus nephritis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Lupus Nephritis; Male; Mycophenolic Acid; Remission Induction; Retrospective Studies; Treatment Outcome | 2010 |
Effect of calcineurin inhibitors in the outcome of liver transplantation in hepatitis C virus-positive recipients.
Topics: Adult; Aged; Antiviral Agents; Biopsy; Calcineurin Inhibitors; Chi-Square Distribution; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Survival; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Prednisone; Prospective Studies; Recurrence; Risk Assessment; Risk Factors; Spain; Tacrolimus; Time Factors; Treatment Outcome | 2010 |
Reversibility of dry eye deceleration after topical cyclosporine 0.05% withdrawal.
Topics: Cell Count; Cyclosporine; Disease Progression; Drug Administration Schedule; Dry Eye Syndromes; Female; Goblet Cells; Humans; Immunosuppressive Agents; Longitudinal Studies; Male; Middle Aged; Ophthalmic Solutions; Prospective Studies; Severity of Illness Index; Single-Blind Method; Substance Withdrawal Syndrome | 2011 |
Prospective 5-year follow-up of cyclosporine treatment in children with steroid-resistant nephrosis.
Topics: Adolescent; Child; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Japan; Kidney; Kidney Failure, Chronic; Male; Methylprednisolone; Nephrosis, Lipoid; Nephrotic Syndrome; Prospective Studies; Recurrence; Remission Induction; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome; Young Adult | 2013 |
Cyclosporin A monotherapy versus cyclosporin A and methotrexate combination therapy in patients with early rheumatoid arthritis: a double blind randomised placebo controlled trial.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Severity of Illness Index; Treatment Outcome | 2003 |
Use of rapamycin slows progression of cardiac transplantation vasculopathy.
Topics: Arterial Occlusive Diseases; Autoantibodies; Cardiac Catheterization; Cohort Studies; Coronary Artery Disease; Cyclosporine; Disease Progression; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Infections; Male; Middle Aged; Neoplasms; Prospective Studies; Renal Insufficiency; Sirolimus; Survival Analysis; Treatment Outcome | 2003 |
Radiographic progression in early rheumatoid arthritis: a 12-month randomized controlled study comparing the combination of cyclosporin and methotrexate with methotrexate alone.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Radiography; Single-Blind Method; Treatment Outcome | 2003 |
Early elimination of cyclosporine in kidney transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Topics: Biopsy; Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Kidney Transplantation; Observer Variation; Sirolimus; Transplantation, Homologous | 2003 |
The remission of nephrotic syndrome with cyclosporin treatment does not attenuate the progression of idiopathic membranous nephropathy.
Topics: Biopsy; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Male; Middle Aged; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction | 2004 |
A randomized controlled trial of immunosuppression conversion for the treatment of chronic allograft nephropathy.
Topics: Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Transplantation; Mycophenolic Acid; Tacrolimus; Transplantation, Homologous | 2004 |
Early cyclosporine a withdrawal in kidney-transplant recipients receiving sirolimus prevents progression of chronic pathologic allograft lesions.
Topics: Adolescent; Adult; Aged; Chronic Disease; Cyclosporine; Disease Progression; Female; Humans; Kidney; Kidney Diseases; Kidney Transplantation; Male; Middle Aged; Sirolimus; Transplantation, Homologous | 2004 |
Etoposide, vincristine, and cyclosporin A with standard-dose radiation therapy in newly diagnosed diffuse intrinsic brainstem gliomas: a pediatric oncology group phase I study.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Brain Stem Neoplasms; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Dose Fractionation, Radiation; Etoposide; Glioma; Humans; Radiotherapy Dosage; Vincristine | 2005 |
Long term efficacy of simvastatin in renal transplant recipients treated with cyclosporine or tacrolimus.
Topics: Adult; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Humans; Hyperlipidemias; Hypolipidemic Agents; Immunosuppressive Agents; Kidney Transplantation; Lipids; Male; Pilot Projects; Prognosis; Simvastatin; Tacrolimus; Time Factors; Treatment Outcome | 2005 |
C1-C2 point monitoring of low-dose cyclosporin a given as a single daily dose in children with steroid-dependent relapsing nephrotic syndrome.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisolone; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome | 2005 |
Complete weaning off immunosuppression in HCV liver transplant recipients is feasible and favourably impacts on the progression of disease recurrence.
Topics: Aged; Cyclosporine; Disease Progression; Female; Hepacivirus; Hepatitis C; Humans; Immunocompetence; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Recurrence; Regression Analysis; RNA, Messenger; RNA, Viral | 2006 |
Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Refractory; Anemia, Refractory, with Excess of Blasts; Aneuploidy; Antilymphocyte Serum; Atrial Fibrillation; Cyclosporine; Disease Progression; Female; Humans; Hypotension; Immunosuppressive Agents; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Prospective Studies; Remission Induction; Risk; T-Lymphocytes; Treatment Outcome | 2006 |
Treatment of severe aplastic anaemia with combined immunosuppression: anti-thymocyte globulin, ciclosporin and mycophenolate mofetil.
Topics: Adolescent; Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Child; Child, Preschool; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Myelodysplastic Syndromes; Recurrence; Survival Analysis; Treatment Outcome | 2006 |
A novel self-microemulsifying formulation of paclitaxel for oral administration to patients with advanced cancer.
Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Cyclosporine; Disease Progression; Drug Administration Schedule; Drug Delivery Systems; Emulsifying Agents; Female; Humans; Male; Maximum Tolerated Dose; Middle Aged; Neoplasms; Paclitaxel; Safety; Solubility; Tissue Distribution; Treatment Outcome | 2006 |
Sirolimus attenuates the rate of progression of early chronic allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Blood Pressure; Chronic Disease; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Middle Aged; Mycophenolic Acid; Postoperative Complications; Sirolimus; Transplantation, Homologous; Treatment Outcome | 2006 |
Protective effects of sirolimus by attenuating connective tissue growth factor expression in human chronic allograft nephropathy.
Topics: Adolescent; Adult; Biopsy; Chronic Disease; Connective Tissue Growth Factor; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Gene Expression Regulation; Humans; Immediate-Early Proteins; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Transplantation; Male; Sirolimus; Survival Analysis; Transplantation, Homologous; Treatment Outcome | 2007 |
Aggressive combination therapy with intra-articular glucocorticoid injections and conventional disease-modifying anti-rheumatic drugs in early rheumatoid arthritis: second-year clinical and radiographic results from the CIMESTRA study.
Topics: Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Arthrography; Betamethasone; Combined Modality Therapy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; Injections, Intra-Articular; Male; Methotrexate; Middle Aged; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2008 |
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A.
Topics: Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Blood Pressure; Creatinine; Cyclosporine; Disease Progression; Female; Humans; Male; Middle Aged; Prospective Studies; Radiography; Severity of Illness Index; Time Factors; Treatment Outcome | 1996 |
Is the control of disease progression within our grasp? Review of the GRISAR study. (Gruppo Reumatologi Italiani Studio Artrite Reumatoide).
Topics: Adult; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Humans; Male; Middle Aged; Prospective Studies; Radiography | 1996 |
Long-term treatment of systemic lupus erythematosus with cyclosporin A.
Topics: Adolescent; Adult; Blood Platelets; Creatinine; Cyclosporine; Disease Progression; Drug Administration Schedule; Female; Hematologic Tests; Humans; Immune System; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Male; Middle Aged; Proteinuria; Treatment Outcome | 1997 |
Treatment of progressive pulmonary sarcoidosis with cyclosporin A. A randomized controlled trial.
Topics: Adult; Bronchoalveolar Lavage Fluid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Prednisone; Prospective Studies; Radiography, Thoracic; Recurrence; Respiratory Mechanics; Sarcoidosis, Pulmonary; Treatment Failure | 1997 |
The inhibitory effects of pravastatin on natural killer cell activity in vivo and on cytotoxic T lymphocyte activity in vitro.
Topics: Adjuvants, Immunologic; Anticholesteremic Agents; Cells, Cultured; Cholesterol; Cholesterol, LDL; Coronary Disease; Cyclosporine; Disease Progression; Drug Synergism; Female; Graft Rejection; Graft Survival; Heart Transplantation; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunosuppressive Agents; Incidence; Killer Cells, Natural; Male; Middle Aged; Pravastatin; T-Lymphocytes, Cytotoxic; Transplantation, Homologous | 1998 |
Progression of joint damage in early active severe rheumatoid arthritis during 18 months of treatment: comparison of low-dose cyclosporin and parenteral gold.
Topics: Adolescent; Adult; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Gold Sodium Thiomalate; Humans; Injections; Male; Middle Aged; Severity of Illness Index; Time Factors | 1998 |
Cyclosporine A therapy for multisystem langerhans cell histiocytosis.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Male; Retrospective Studies; Treatment Outcome | 1999 |
Influence of cyclosporin A on radiological progression in early rheumatoid arthritis patients: a 42-month prospective study.
Topics: Adolescent; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Female; Hand; Humans; Hypertension; Male; Methotrexate; Nausea; Prospective Studies; Radiography; Time Factors; Wrist | 2000 |
Mycophenolate mofetil prevents the progression of chronic kidney allograft nephropathy.
Topics: Adult; Azathioprine; Biopsy; Creatinine; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Systole; Transplantation, Homologous | 2000 |
[Therapeutic efficacy of cyclosporin A in four cases of amyopathic dermatomyositis with rapidly progressive interstitial pneumonia].
Topics: Adult; Aged; Cyclosporine; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Middle Aged; Oxygen; Partial Pressure; Respiratory Insufficiency; Treatment Outcome | 2000 |
182 other study(ies) available for cyclosporine and Disease Exacerbation
| Article | Year |
|---|---|
Risankizumab-induced paradoxical pustular psoriasis.
Topics: Antibodies, Monoclonal; Cyclosporine; Dermatologic Agents; Disease Progression; Female; Humans; Interleukin-23 Subunit p19; Middle Aged; Psoriasis | 2022 |
Clinical Manifestations and Treatment of Vogt-Koyanagi-Harada Disease during Pregnancy and after Birth: A Case Report.
Topics: Acute Disease; Choroid; Cyclosporine; Disease Progression; Female; Humans; Pregnancy; Uveomeningoencephalitic Syndrome | 2023 |
Clinical outcomes and effects of treatment in older patients with idiopathic membranous nephropathy.
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Aged; Communicable Diseases; Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Remission Induction; Renal Replacement Therapy; Retrospective Studies; Risk Assessment; Risk Factors; Seoul; Time Factors; Treatment Outcome | 2019 |
Chronic inflammatory demyelinating polyneuropathy: Plasmapheresis or cyclosporine can be good treatment options in refractory cases.
Topics: Adolescent; Azathioprine; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Glucocorticoids; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Methylprednisolone; Plasmapheresis; Polyradiculoneuropathy, Chronic Inflammatory Demyelinating; Treatment Failure; Treatment Outcome | 2019 |
Clinical course of acute deep vein thrombosis of the legs in Behçet's syndrome.
Topics: Adult; Azathioprine; Behcet Syndrome; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Femoral Vein; Glucocorticoids; Humans; Iliac Vein; Immunosuppressive Agents; Interferon-alpha; Lower Extremity; Male; Methylprednisolone; Popliteal Vein; Prednisolone; Proportional Hazards Models; Recurrence; Treatment Outcome; Ultrasonography, Doppler; Vena Cava, Inferior; Venous Thrombosis; Young Adult | 2020 |
Egyptian experience in Langerhans cells histiocytosis: frequent multisystem affection and reactivation rates.
Topics: Child; Child, Preschool; Cladribine; Cyclosporine; Disease Progression; Egypt; Female; Histiocytosis, Langerhans-Cell; Humans; Infant; Langerhans Cells; Liver; Lymph Nodes; Lymphohistiocytosis, Hemophagocytic; Male; Recurrence; Retrospective Studies; Risk Factors; Survival Rate; Treatment Outcome | 2020 |
The Secretome Analysis of Activated Human Renal Fibroblasts Revealed Beneficial Effect of the Modulation of the Secreted Peptidyl-Prolyl Cis-Trans Isomerase A in Kidney Fibrosis.
Topics: Cell Line, Transformed; Cell Survival; Cyclosporine; Disease Progression; Down-Regulation; Extracellular Matrix; Fibroblasts; Fibronectins; Fibrosis; Humans; Inflammation; Kidney; Peptidylprolyl Isomerase; Phenotype; Proteome; RNA, Small Interfering; Tacrolimus | 2020 |
Dupilumab-associated ocular surface disease: presentation, management and long-term sequelae.
Topics: Antibodies, Monoclonal, Humanized; Conjunctivitis; Cyclosporine; Dermatitis, Atopic; Disease Progression; Eye Diseases; Humans; Retrospective Studies; Severity of Illness Index; Treatment Outcome | 2021 |
Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents.
Topics: Aged; Aged, 80 and over; Anemia; Antilymphocyte Serum; Antineoplastic Agents; Arsenic; Azacitidine; Chromosome Deletion; Chromosomes, Human, Pair 5; Cyclosporine; Cytarabine; Decitabine; Disease Progression; Enzyme Inhibitors; Erythrocyte Transfusion; Female; Hematinics; Humans; Hydroxyurea; Immunologic Factors; Lenalidomide; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Recurrence; Retreatment; Retrospective Studies; Risk Factors; Survival Rate; Thalidomide; Treatment Failure; Tretinoin; Valproic Acid | 2017 |
[Acquired amegacaryocytic thrombocytopenic purpura hiding acute myeloid leukemia].
Topics: Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Leukemia, Myeloid, Acute; Male; Megakaryocytes; Myelography; Purpura, Thrombocytopenic; Young Adult | 2017 |
Successful Use of Cyclosporin A for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Three Children.
Topics: Boston; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Infant; Length of Stay; Male; Skin; Stevens-Johnson Syndrome; Time Factors; Treatment Outcome | 2017 |
Cyclosporine for the treatment of lupus nephritis in patients with systemic lupus erythematosus.
Topics: Adult; Biopsy; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Glomerular Filtration Rate; Humans; Immunosuppressive Agents; Kidney; Lupus Erythematosus, Systemic; Lupus Nephritis; Male; Recurrence; Remission Induction; Retrospective Studies; Treatment Outcome; Young Adult | 2018 |
Circulating serum interleukin-6, serum chitinase-3-like protein-1, and plasma vascular endothelial growth factor are not predictive for remission and radiographic progression in patients with early rheumatoid arthritis: post-hoc explorative and validation
Topics: Adalimumab; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Female; Forefoot, Human; Hand Joints; Humans; Interleukin-6; Male; Methotrexate; Middle Aged; Prognosis; Radiography; Randomized Controlled Trials as Topic; Remission Induction; Severity of Illness Index; Vascular Endothelial Growth Factor A | 2018 |
Cyclosporine for Epidermal Necrolysis: Absence of Beneficial Effect in a Retrospective Cohort of 174 Patients-Exposed/Unexposed and Propensity Score-Matched Analyses.
Topics: Acute Kidney Injury; Adult; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Palliative Care; Propensity Score; Re-Epithelialization; Retrospective Studies; Skin; Stevens-Johnson Syndrome; Survival Analysis; Treatment Failure | 2018 |
Successful treatment of plasma exchange for rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive dermatomyositis: A case report.
Topics: Aged; Autoantibodies; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Female; Ferritins; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Methylprednisolone; Mucin-1; Plasma Exchange; Prednisolone; Prognosis | 2018 |
Clinical Features of Chronic Spontaneous Urticaria that Predict Disease Prognosis and Refractoriness to Standard Treatment.
Topics: Adult; Age of Onset; Aged; Chronic Disease; Cyclosporine; Disease Progression; Drug Resistance; Female; Histamine H1 Antagonists; Humans; Immunosuppressive Agents; Male; Middle Aged; Omalizumab; Recurrence; Retrospective Studies; Risk Factors; Time Factors; Treatment Failure; Urticaria | 2018 |
Outcomes and mutational analysis of patients with lower-risk non-del5q myelodysplastic syndrome treated with antithymocyte globulin with or without ciclosporine A.
Topics: Aged; Antilymphocyte Serum; Cyclosporine; Disease Progression; DNA Mutational Analysis; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Treatment Outcome | 2018 |
Chronic Bullous Dermatosis of Childhood and the String of Pearls Sign.
Topics: Biopsy, Needle; Child, Preschool; Cyclosporine; Dapsone; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Emergency Service, Hospital; Humans; Immunohistochemistry; Linear IgA Bullous Dermatosis; Male; Prednisolone; Rare Diseases; Risk Assessment; Severity of Illness Index; Skin Diseases, Vesiculobullous; Treatment Outcome | 2018 |
Ruxolitinib inhibits cyclosporine-induced proliferation of cutaneous squamous cell carcinoma.
Topics: Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Cyclosporine; Disease Models, Animal; Disease Progression; Female; Gene Expression Regulation, Neoplastic; Heterografts; Humans; Interleukin-22; Interleukins; Janus Kinase 1; Mice; Mice, Nude; Nitriles; Organ Transplantation; Pyrazoles; Pyrimidines; Receptors, Interleukin; Signal Transduction; Skin Neoplasms; STAT1 Transcription Factor; STAT3 Transcription Factor | 2018 |
Superficial granulomatous pyoderma in a patient with ulcerative colitis successfully treated with cyclosporine A.
Topics: Biopsy; Clobetasol; Colitis, Ulcerative; Cyclosporine; Debridement; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Leg; Middle Aged; Pyoderma Gangrenosum; Skin; Treatment Outcome | 2019 |
[A case of antisynthetase syndrome with anti-EJ antibody complicated by pericarditis].
Topics: Aged; Autoantibodies; Biomarkers; Cyclosporine; Disease Progression; Glycine-tRNA Ligase; Humans; Male; Methylprednisolone; Myositis; Pericarditis; Prednisolone; Pulse Therapy, Drug; Rectal Neoplasms; Treatment Outcome | 2019 |
Corticosteroid treatment exacerbates nephrotic syndrome in a zebrafish model of magi2a knockout.
Topics: Animals; Animals, Genetically Modified; Cyclosporine; Disease Models, Animal; Disease Progression; Drug Resistance; Gene Knockout Techniques; Glucocorticoids; Humans; Immunosuppressive Agents; Membrane Proteins; Monomeric GTP-Binding Proteins; Nephrotic Syndrome; Podocytes; Proteinuria; Signal Transduction; Tacrolimus; Treatment Outcome; Zebrafish; Zebrafish Proteins | 2019 |
Rapid perturbation in viremia levels drives increases in functional avidity of HIV-specific CD8 T cells.
Topics: Anti-Retroviral Agents; Antibodies, Viral; Antibody Affinity; CD8-Positive T-Lymphocytes; Chronic Disease; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Disease Progression; Epitope Mapping; HIV; HIV Infections; Humans; Immunity, Cellular; Immunosuppressive Agents; Longitudinal Studies; Receptors, Antigen, T-Cell; Up-Regulation; Viremia; Virus Replication | 2013 |
Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.
Topics: Adolescent; Anemia, Aplastic; Animals; Antilymphocyte Serum; Cell Transformation, Neoplastic; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Horses; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Prognosis; Rabbits; Recurrence; Retrospective Studies; Risk Factors; Severity of Illness Index; Treatment Outcome | 2014 |
Hemophagocytic syndrome diagnosed by liver biopsy in a female patient with systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Cyclosporine; Disease Progression; Female; Humans; Liver; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; Prednisolone; Young Adult | 2013 |
Childhood Cogan syndrome with aortitis and anti-neutrophil cytoplasmic antibody-associated glomerulonephritis.
Topics: Adolescent; Adult; Antibodies, Antineutrophil Cytoplasmic; Antirheumatic Agents; Aortitis; Aspirin; Cataract; Cogan Syndrome; Cyclosporine; Disease Progression; Glomerulonephritis; Hearing Loss, Sensorineural; Humans; Kidney; Kidney Function Tests; Magnetic Resonance Angiography; Male; Prednisolone | 2014 |
Clinical characteristics and treatment outcome in 65 cases with refractory cytopenia of childhood defined according to the WHO 2008 classification.
Topics: Adolescent; Antilymphocyte Serum; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Infant; Infant, Newborn; Male; Myelodysplastic Syndromes; Pancytopenia; Prospective Studies; Treatment Outcome; World Health Organization | 2014 |
Clinical and serological predictors of remission in rheumatoid arthritis are dependent on treatment regimen.
Topics: Adult; Age Factors; Aged; Antirheumatic Agents; Arthritis, Rheumatoid; Autoantibodies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Male; Methotrexate; Middle Aged; Peptides, Cyclic; Prednisolone; Remission Induction; Rheumatoid Factor; Sex Factors; Treatment Outcome | 2014 |
Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine.
Topics: Adult; Aged; Cyclosporine; Disease Progression; Female; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Immunosuppressive Agents; Male; Middle Aged; Retrospective Studies; Severity of Illness Index; Stevens-Johnson Syndrome; Survival Rate | 2014 |
Erythrodermic CD8+ pseudolymphoma during infliximab treatment in a patient with psoriasis: use of cyclosporine as a rescue therapy.
Topics: Adult; Antibodies, Monoclonal; Biopsy, Needle; CD8 Antigens; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Humans; Immunohistochemistry; Infliximab; Pseudolymphoma; Psoriasis; Risk Assessment; Severity of Illness Index; Skin Diseases; Treatment Outcome | 2014 |
M-type phospholipase A2 receptor autoantibodies and renal function in patients with primary membranous nephropathy.
Topics: Adult; Age Factors; Aged; Antibodies, Monoclonal, Murine-Derived; Autoantibodies; Creatinine; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Glomerulonephritis, Membranous; Humans; Immunosuppressive Agents; Male; Middle Aged; Prospective Studies; Proteins; Proteinuria; Receptors, Phospholipase A2; Rituximab; Sex Factors | 2014 |
Regulatory T cell levels and cytokine production in active non-infectious uveitis: in-vitro effects of pharmacological treatment.
Topics: Adult; Antibodies, Monoclonal; Cells, Cultured; Cyclosporine; Cytokines; Dexamethasone; Disease Progression; Female; Forkhead Transcription Factors; Humans; Infliximab; Lymphocyte Count; Male; Middle Aged; T-Lymphocytes, Regulatory; Uveitis; Young Adult | 2015 |
Long-Term Impact of Different Immunosuppressive Drugs on QT and PR Intervals in Renal Transplant Patients.
Topics: Adult; Arrhythmias, Cardiac; Azathioprine; Cyclosporine; Death, Sudden, Cardiac; Disease Progression; Electrocardiography; Everolimus; Female; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Tacrolimus | 2015 |
The role of NFATc1 in prostate cancer progression: cyclosporine A and tacrolimus inhibit cell proliferation, migration, and invasion.
Topics: Animals; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclosporine; Disease Progression; Humans; Male; Mice; Neoplasm Invasiveness; NFATC Transcription Factors; Prostatic Neoplasms; Tacrolimus; Xenograft Model Antitumor Assays | 2015 |
Vernal Keratoconjunctivitis and immune-mediated diseases: One unique way to symptom control?
Topics: Adolescent; Asthma; Conjunctivitis, Allergic; Cyclosporine; Dermatitis, Atopic; Disease Progression; Humans; Immunoglobulin E; Male; Omalizumab; Th1 Cells; Th2 Cells | 2015 |
Cyclosporine Combined with Levamisole for Lower-Risk Myelodysplastic Syndromes.
Topics: Adjuvants, Immunologic; Adolescent; Adult; Child; Cyclosporine; Disease Progression; Female; Humans; Levamisole; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies; Survival Analysis; Young Adult | 2015 |
Methotrexate, Cyclosporine A, and Biologics Protect against Atherosclerosis in Rheumatoid Arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Atherosclerosis; Biological Products; Carotid Intima-Media Thickness; Case-Control Studies; Cyclosporine; Disease Progression; Female; Humans; Male; Methotrexate; Middle Aged; Prevalence; Severity of Illness Index | 2015 |
Survival benefit associated with early cyclosporine treatment for dermatomyositis-associated interstitial lung disease.
Topics: Adult; Cyclosporine; Dermatomyositis; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methotrexate; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Survival Rate; Time Factors | 2016 |
Interstitial lung disease in clinically amyopathic dermatomyositis with and without anti-MDA-5 antibody: to lump or split?
Topics: Adrenal Cortex Hormones; Aged; Antibodies; Biomarkers; Cyclophosphamide; Cyclosporine; DEAD-box RNA Helicases; Dermatomyositis; Disease Progression; Female; Humans; Interferon-Induced Helicase, IFIH1; Lung Diseases, Interstitial; Male; Middle Aged; Prognosis; Respiratory Function Tests; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
Rapid Response to Cyclosporin A and Favorable Renal Outcome in Nongenetic Versus Genetic Steroid-Resistant Nephrotic Syndrome.
Topics: Adolescent; Austria; Biopsy; Child; Child, Preschool; Cross-Sectional Studies; Cyclosporine; Disease Progression; DNA Mutational Analysis; Female; Genetic Predisposition to Disease; Germany; Humans; Immunosuppressive Agents; Infant; Intracellular Signaling Peptides and Proteins; Kidney; Kidney Failure, Chronic; Longitudinal Studies; Male; Membrane Proteins; Mutation; Nephrotic Syndrome; Phenotype; Recovery of Function; Remission Induction; Risk Factors; Time Factors; Treatment Outcome; WT1 Proteins | 2016 |
Calcineurin Inhibitor Nephrotoxicity Through the Lens of Longitudinal Histology: Comparison of Cyclosporine and Tacrolimus Eras.
Topics: Adult; Biopsy; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Incidence; Intention to Treat Analysis; Kaplan-Meier Estimate; Kidney; Kidney Diseases; Kidney Transplantation; Longitudinal Studies; Male; New South Wales; Prevalence; Proportional Hazards Models; Risk Factors; Tacrolimus; Time Factors; Treatment Outcome | 2016 |
Blood concentration of aminothiols in children with relapse of nephrotic syndrome.
Topics: Adolescent; Biomarkers; Biopsy, Needle; Child; Child, Preschool; Chromatography, High Pressure Liquid; Cohort Studies; Cross-Sectional Studies; Cyclosporine; Dipeptides; Disease Progression; Female; Follow-Up Studies; Glutathione; Homocysteine; Humans; Immunohistochemistry; Male; Nephrotic Syndrome; Recurrence; Risk Assessment; Sensitivity and Specificity; Severity of Illness Index; Sulfhydryl Compounds; Treatment Outcome | 2016 |
[Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Topics: Biomarkers; Collagen Type IV; Cyclosporine; Diagnosis, Differential; Disease Progression; Genetic Counseling; Glomerular Basement Membrane; Humans; Immunosuppressive Agents; Mutation; Nephritis, Hereditary; Treatment Outcome | 2016 |
Clinical Trials in FSGS: Past Challenges and New Trial Designs.
Topics: Adaptive Clinical Trials as Topic; Adult; Child; Clinical Trials as Topic; Cyclosporine; Disease Progression; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Mycophenolic Acid; Nephrotic Syndrome; Patient Reported Outcome Measures; Proteinuria; Research Design | 2016 |
Acute kidney injury in idiopathic nephrotic syndrome of childhood is a major risk factor for the development of chronic kidney disease.
Topics: Acute Kidney Injury; Adolescent; Child; Child, Preschool; Cyclosporine; Disease Progression; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney; Kidney Function Tests; Male; Nephrotic Syndrome; Pakistan; Prognosis; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors | 2017 |
The effect of aldosterone antagonist in experimental nephropathy induced by cyclosporine A.
Topics: Animals; Creatinine; Cyclosporine; Disease Models, Animal; Disease Progression; Glomerular Filtration Rate; Kidney; Male; Mineralocorticoid Receptor Antagonists; Nephrotic Syndrome; Probability; Proteinuria; Random Allocation; Rats; Rats, Wistar; Reference Values; Risk Assessment; Sensitivity and Specificity; Spironolactone; Statistics, Nonparametric | 2008 |
[Pyoderma gangrenosum--an interdisciplinary diagnostic problem].
Topics: Cyclosporine; Disease Progression; Female; Humans; Middle Aged; Prednisone; Pyoderma Gangrenosum; Remission Induction; Skin Ulcer | 2008 |
Pemphigus mouse model as a tool to evaluate various immunosuppressive therapies.
Topics: Animals; Azathioprine; Body Weight; Cyclophosphamide; Cyclosporine; Desmoglein 3; Dexamethasone; Disease Models, Animal; Disease Progression; Female; Immunoglobulin G; Immunosuppressive Agents; Male; Methylprednisolone; Mice; Mice, Inbred C57BL; Mice, Knockout; Pemphigus; Phenotype; Tacrolimus | 2009 |
Clinicopathologic correlation and outcome of C1q nephropathy.
Topics: Adolescent; Adult; Aged; Child; Child, Preschool; Complement C1q; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulonephritis, Membranoproliferative; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Kidney Failure, Chronic; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisolone; Recurrence; Time Factors; Treatment Outcome; Young Adult | 2008 |
Long-term graft outcome in patients with chronic allograft nephropathy after immunosuppression modifications.
Topics: Adult; Azathioprine; Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Kidney Diseases; Kidney Function Tests; Kidney Transplantation; Male; Middle Aged; Mycophenolic Acid; Retrospective Studies; Tacrolimus; Time Factors; Transplantation, Homologous; Treatment Outcome | 2009 |
Effects of immunosuppressants on the progression of hepatitis C in hepatitis C virus-positive renal transplantation and the usefulness of interferon therapy.
Topics: Alanine Transaminase; Cyclosporine; Disease Progression; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Immunosuppressive Agents; Japan; Kidney Transplantation; Postoperative Complications; Retrospective Studies; RNA, Viral; Tacrolimus; Virus Replication | 2008 |
Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
Topics: Animals; Breast Neoplasms; Cells, Cultured; Cyclophilin A; Cyclosporine; Disease Progression; Drug Synergism; Enzyme Inhibitors; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Janus Kinase 2; Mice; Mice, Nude; Peptidylprolyl Isomerase; Prolactin; Transplantation, Heterologous | 2008 |
Renal function in pediatric liver transplantation: a long-term follow-up study.
Topics: Adolescent; Adult; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Incidence; Infant; Inulin; Kaplan-Meier Estimate; Liver Diseases; Liver Transplantation; Male; Proportional Hazards Models; Renal Insufficiency, Chronic; Risk Assessment; Risk Factors; Severity of Illness Index; Survivors; Time Factors | 2008 |
The top 10 things nephrologists wish every primary care physician knew.
Topics: Aluminum; Anemia; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antacids; Blood Pressure; Blood Urea Nitrogen; Cardiovascular Diseases; Cathartics; Chronic Disease; Contraindications; Creatinine; Cyclosporine; Disease Progression; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Erythropoietin; Evidence-Based Medicine; Glomerular Filtration Rate; Humans; Hypertension; Immunosuppressive Agents; Kidney Diseases; Magnesium; Nephrolithiasis; Nephrology; Phosphates; Primary Health Care; Proteinuria; Recombinant Proteins; Referral and Consultation; Tacrolimus; Urinalysis | 2009 |
Hyperferritinemia as the diagnostic clue in life-threatening hemophagocytic lymphohistiocytosis.
Topics: Abdominal Pain; Adolescent; Anti-Inflammatory Agents; Caprylates; Combined Modality Therapy; Cyclosporine; Diagnosis, Differential; Disease Progression; Female; Ferritins; Humans; Immunoglobulins, Intravenous; Immunosuppressive Agents; Intensive Care Units, Pediatric; Killer Cells, Natural; Lymphohistiocytosis, Hemophagocytic; Methylprednisolone; T-Lymphocytes; Unnecessary Procedures | 2009 |
Renal function and cardiovascular risk profile after conversion from ciclosporin to tacrolimus: prospective study in 80 liver transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Chronic Disease; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Humans; Immunosuppressive Agents; Kidney Diseases; Kidney Function Tests; Liver Diseases; Liver Transplantation; Male; Middle Aged; Prospective Studies; Risk Factors; Tacrolimus; Treatment Outcome | 2009 |
Risk factors for cyclosporin A nephrotoxicity in children with steroid-dependant nephrotic syndrome.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Humans; Hypertension; Hyperuricemia; Immunosuppressive Agents; Infant; Kidney Diseases; Logistic Models; Male; Nephrotic Syndrome; Odds Ratio; Retrospective Studies; Risk Assessment; Risk Factors; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Erosive mucosal lichen planus and secondary epiphora responding to systemic cyclosporin A treatment.
Topics: Biopsy, Needle; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Immunohistochemistry; Lacrimal Apparatus Diseases; Lichen Planus; Lichen Planus, Oral; Middle Aged; Mouth Mucosa; Severity of Illness Index; Treatment Outcome; Vulvar Diseases | 2009 |
Protective effects of Mizoribine on Cyclosporine A nephropathy in rats.
Topics: Animals; Anti-Inflammatory Agents; Body Weight; Cyclosporine; Disease Progression; Fibrosis; Immunohistochemistry; Immunosuppressive Agents; Inflammation; Kidney; Kidney Diseases; Male; Rats; Rats, Sprague-Dawley; Reverse Transcriptase Polymerase Chain Reaction; Ribonucleosides | 2009 |
Immunosuppressive treatment in patient with pure red cell aplasia associated with chronic myelomonocytic leukemia: harm or benefit?
Topics: Cell Transformation, Neoplastic; Cyclosporine; Disease Progression; Fatal Outcome; Female; Humans; Immunosuppressive Agents; Leukemia, Myelomonocytic, Chronic; Middle Aged; Red-Cell Aplasia, Pure; Steroids | 2009 |
Ocular myasthenia gravis in a senior population: diagnosis, therapy, and prognosis.
Topics: Age Factors; Age of Onset; Aged; Aged, 80 and over; Azathioprine; Chi-Square Distribution; Cyclosporine; Disease Progression; Disease-Free Survival; Electric Stimulation; Electromyography; Female; Humans; Immunotherapy; Male; Myasthenia Gravis; Patient Selection; Plasma Exchange; Prednisone; Prognosis; Remission Induction; Retrospective Studies; Severity of Illness Index; Thymectomy; Treatment Outcome | 2010 |
Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Glomerulosclerosis, Focal Segmental; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Kidney Transplantation; Male; Methylprednisolone; Nephrectomy; Plasmapheresis; Proteinuria; Recurrence; Risk Factors; Survival Analysis; Treatment Outcome; Young Adult | 2010 |
Cyclosporin A in the treatment of acute exacerbation of idiopathic pulmonary fibrosis.
Topics: Acute Disease; Aged; Aged, 80 and over; Cyclosporine; Disease Progression; Female; Humans; Idiopathic Pulmonary Fibrosis; Male; Middle Aged; Retrospective Studies; Survival Rate; Treatment Outcome | 2010 |
Clinical and pathological findings of interstitial lung disease patients with anti-aminoacyl-tRNA synthetase autoantibodies.
Topics: Adrenal Cortex Hormones; Adult; Aged; Amino Acyl-tRNA Synthetases; Autoantibodies; Cyclosporine; Disease Progression; Female; Humans; Lung; Lung Diseases, Interstitial; Male; Middle Aged; Retrospective Studies; Treatment Outcome | 2010 |
Prospective study of switch from cyclosporine to tacrolimus for fibroadenomas of the breast in kidney transplantation.
Topics: Adult; Breast Neoplasms; Cyclosporine; Disease Progression; Estradiol; Female; Fibroadenoma; Follicle Stimulating Hormone; Humans; Immunosuppressive Agents; Kidney Transplantation; Mastectomy, Segmental; Middle Aged; Progesterone; Prolactin; Tacrolimus; Young Adult | 2010 |
Selectively high levels of serum interleukin 17 in a newborn infant with progressive severe cholestasis.
Topics: Biomarkers; Cholestasis; Cyclosporine; Disease Progression; Drug Therapy, Combination; Follow-Up Studies; Humans; Infant, Newborn; Interleukin-17; Interleukin-8; Macrophage Inflammatory Proteins; Male; Risk Assessment; Severity of Illness Index; Steroids; Treatment Outcome | 2010 |
Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease Progression; DNA Mutational Analysis; Drug Resistance; Female; Genes, Wilms Tumor; Genetic Predisposition to Disease; Germany; Heredity; Hospitals, Pediatric; Hospitals, University; Humans; Immunosuppressive Agents; Infant; Intracellular Signaling Peptides and Proteins; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Laminin; Male; Membrane Proteins; Mutation; Nephrotic Syndrome; Patient Selection; Phenotype; Retrospective Studies; Steroids; Time Factors; Treatment Outcome; TRPC Cation Channels; TRPC6 Cation Channel | 2010 |
Early and delayed effects of AST-120 on chronic cyclosporine nephropathy.
Topics: Animals; Blotting, Northern; Blotting, Western; Carbon; Chronic Disease; Cyclosporine; Disease Progression; Immunoenzyme Techniques; Immunosuppressive Agents; In Situ Hybridization; Kidney Diseases; Male; Microspheres; Oxidative Stress; Oxides; Rats; Rats, Sprague-Dawley | 2011 |
Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis.
Topics: Animals; Bile Ducts; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Everolimus; Fatty Liver; Immunosuppressive Agents; Ligation; Liver Cirrhosis, Experimental; Male; Matrix Metalloproteinases; Non-alcoholic Fatty Liver Disease; Portal Pressure; Rats; Rats, Wistar; RNA, Messenger; Sirolimus; Tacrolimus; TOR Serine-Threonine Kinases; Triglycerides | 2011 |
Results of a two-center study comparing hepatic fibrosis progression in HCV-positive liver transplant patients receiving cyclosporine or tacrolimus.
Topics: Cyclosporine; Disease Progression; Female; Hepatitis C; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Tacrolimus | 2010 |
Imatinib combined with myeloablative allogeneic hematopoietic stem cell transplantation for advanced phases of chronic myeloid leukemia.
Topics: Adult; Benzamides; Blast Crisis; Busulfan; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Myeloablative Agonists; Piperazines; Pyrimidines; Remission Induction; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2011 |
British Society of Gastroenterology (BSG) guidelines for management of autoimmune hepatitis.
Topics: Adult; Anti-Inflammatory Agents; Azathioprine; Cyclosporine; Diagnosis, Differential; Disease Progression; Female; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Long-Term Care; Prednisolone; Pregnancy; Pregnancy Complications; Secondary Prevention; Severity of Illness Index | 2011 |
The use of selective immunosuppressive therapy on myelodysplastic syndromes in targeted populations results in good response rates and avoids treatment-related disease progression.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Bone Marrow Cells; Cell Transformation, Neoplastic; Child; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Karyotype; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; T-Lymphocytes; Treatment Outcome; Young Adult | 2012 |
Prevalence and outcome of focal segmental glomerulosclerosis in Iranian children with nephrotic syndrome.
Topics: Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Incidence; Iran; Kaplan-Meier Estimate; Kidney Failure, Chronic; Male; Mycophenolic Acid; Nephrotic Syndrome; Prevalence; Proportional Hazards Models; Steroids; Treatment Outcome | 2012 |
Prophylaxis of chronic kidney disease after liver transplantation--experience from west China.
Topics: Adult; Aged; Calcineurin Inhibitors; China; Cyclosporine; Disease Progression; Female; Graft Survival; Humans; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Renal Insufficiency, Chronic; Retrospective Studies; Risk Factors; Tacrolimus; Young Adult | 2012 |
Interstitial pneumonia and nodular regenerative hyperplasia of the liver as initial manifestations of polyarteritis nodosa.
Topics: Aged; Cyclosporine; Disease Progression; Dyspnea; Fatal Outcome; Humans; Hyperplasia; Hypertension, Portal; Immunosuppressive Agents; Liver Failure; Liver Regeneration; Lung Diseases, Interstitial; Male; Polyarteritis Nodosa; Prednisolone; Tomography, X-Ray Computed | 2012 |
Massive tension pneumomediastinum.
Topics: Adult; Bronchiectasis; Cough; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Fatal Outcome; Female; Fever; Humans; Immunosuppressive Agents; Mediastinal Emphysema; Prednisolone; Subcutaneous Emphysema; Tomography, X-Ray Computed | 2012 |
Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.
Topics: Adult; Age Factors; Aged; Arterioles; Biopsy; Cyclosporine; Diabetes Mellitus; Disease Progression; Female; Glomerular Filtration Rate; Humans; Hyalin; Hypertension; Immunosuppressive Agents; Kidney; Kidney Transplantation; Male; Middle Aged; Observer Variation; Reproducibility of Results; Retrospective Studies; Tacrolimus; Tissue Donors | 2012 |
Membranous nephropathy with renal salt wasting: role of neurohumoral factors in sodium retention.
Topics: Blood Chemical Analysis; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Female; Follow-Up Studies; Glomerulonephritis, Membranous; Humans; Hypernatremia; Kidney Function Tests; Middle Aged; Nephrotic Syndrome; Neurotransmitter Agents; Prednisone; Risk Assessment; Severity of Illness Index; Treatment Outcome | 2012 |
Nonfunction of the ECT2 gene may cause renal tubulointerstitial injury leading to focal segmental glomerulosclerosis.
Topics: Biopsy; Child; Cyclosporine; Disease Progression; Epithelial Cells; Genotype; Glomerulosclerosis, Focal Segmental; Humans; Kidney; Kidney Transplantation; Male; Nephritis, Interstitial; Proto-Oncogene Proteins; Tight Junctions; Treatment Outcome; Young Adult | 2012 |
A clinicopathologic study of primary focal segmental glomerulosclerosis in children.
Topics: Adolescent; Age Factors; Biopsy; Child; Child, Preschool; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Fluorescent Antibody Technique; Glomerulosclerosis, Focal Segmental; Humans; Immunosuppressive Agents; Infant; Kidney Glomerulus; Male; Microscopy, Electron; Nephrotic Syndrome; Pakistan; Remission Induction; Renal Insufficiency; Retrospective Studies; Steroids; Tacrolimus; Treatment Outcome | 2012 |
[Case of immunosuppressant-resistant amyopathic dermatomyositis with rapidly progressive interstitial pneumonia ameliorated after resection of gastric cancer].
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Resistance; Drug Therapy, Combination; Female; Gastrectomy; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Pulse Therapy, Drug; Stomach Neoplasms; Treatment Outcome | 2012 |
YKL-40-gene polymorphism affects acute cellular rejection and fibrosis progression after transplantation for hepatitis C virus-induced liver disease.
Topics: Adipokines; Adult; Antiviral Agents; Chitinase-3-Like Protein 1; Cyclosporine; Disease Progression; Drug Therapy, Combination; End Stage Liver Disease; Female; Genotype; Graft Rejection; Hepacivirus; Hepatitis C; Humans; Immunosuppressive Agents; Interferon alpha-2; Interferon-alpha; Lectins; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Mycophenolic Acid; Polyethylene Glycols; Polymorphism, Single Nucleotide; Recombinant Proteins; Ribavirin; Sex Factors; Statistics, Nonparametric; Tacrolimus; Time Factors; Young Adult | 2013 |
Does treatment with corticosteroids and cyclosporine reduce transglutaminase type 2 expression in the renal tissue of patients with membranous nephropathy?
Topics: Adult; Aged; Anti-Inflammatory Agents; Biomarkers; Case-Control Studies; Creatinine; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Fibrosis; Follow-Up Studies; Glomerulonephritis, Membranous; GTP-Binding Proteins; Humans; Immunosuppressive Agents; Linear Models; Male; Middle Aged; Prednisolone; Protein Glutamine gamma Glutamyltransferase 2; Statistics, Nonparametric; Transglutaminases; Treatment Outcome | 2012 |
Cyclosporine rescue therapy in autoimmune liver cirrhosis: a case report.
Topics: Autoimmune Diseases; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Immunosuppressive Agents; Liver Cirrhosis; Middle Aged | 2012 |
The progression risk factors of children with transfusion-independent non-severe aplastic anemia.
Topics: Adolescent; Anemia, Aplastic; Blood Transfusion; Child; Child, Preschool; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Humans; Infant; Male; Palliative Care; Prognosis; Retrospective Studies; Risk Factors; Stanozolol | 2013 |
Rapidly progressive interstitial lung disease in a dermatomyositis patient with high levels of creatine phosphokinase, severe muscle symptoms and positive anti-Jo-1 antibody.
Topics: Anti-Inflammatory Agents; Autoantibodies; Creatine Kinase; Cyclosporine; Dermatomyositis; Disease Progression; Female; Histidine-tRNA Ligase; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Middle Aged; Muscular Diseases; Prognosis; Steroids; Tomography, X-Ray Computed; Treatment Outcome | 2002 |
Time-dependent systolic and diastolic function in mice overexpressing calcineurin.
Topics: Animals; Calcineurin; Cardiomegaly; Cyclosporine; Death, Sudden, Cardiac; Diastole; Disease Progression; Echocardiography; Heart; Heart Ventricles; Mice; Mice, Transgenic; Survival Analysis; Systole; Time Factors | 2003 |
The effect of two different cyclosporine formulations on the long-term progression to chronic rejection in renal allograft recipients.
Topics: Adult; Cyclosporine; Disease Progression; Emulsions; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Living Donors; Retrospective Studies | 2002 |
Impact of cyclosporine dosing frequency on graft function and survival after the conversion from sandimmun to neoral in stable kidney transplanted patients.
Topics: Administration, Oral; Adult; Chemistry, Pharmaceutical; Cyclosporine; Disease Progression; Drug Administration Schedule; Ethnicity; Female; Graft Survival; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Transplantation; Living Donors; Male; Reoperation; Retrospective Studies; Survival Analysis; Time Factors; Tissue Donors | 2002 |
Effect of mycophenolate mofetil on progression of chronic allograft nephropathy.
Topics: Chronic Disease; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Kidney Function Tests; Kidney Transplantation; Lymphocyte Activation; Male; Mycophenolic Acid; Regression Analysis; Transplantation, Homologous | 2003 |
Cyclosporine a slows the progressive renal disease of alport syndrome (X-linked hereditary nephritis): results from a canine model.
Topics: Animals; Body Weight; Creatinine; Cyclosporine; Disease Models, Animal; Disease Progression; Dogs; Fibrosis; Immunosuppressive Agents; Kidney Concentrating Ability; Kidney Glomerulus; Male; Nephritis, Hereditary; Proteinuria | 2003 |
Interstitial lung disease associated with juvenile dermatomyositis: clinical features and efficacy of cyclosporin A.
Topics: Adolescent; Anti-Inflammatory Agents; Child; Child, Preschool; Cryptogenic Organizing Pneumonia; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Prednisolone; Prognosis; Vital Capacity | 2003 |
Expression of macrophage inflammatory protein-3 beta/CCL19 in pulmonary sarcoidosis.
Topics: Adult; Aged; Bronchoalveolar Lavage Fluid; Case-Control Studies; Chemokine CCL19; Chemokine CCL20; Chemokines, CC; Cyclosporine; Dexamethasone; Disease Progression; Down-Regulation; Female; Gene Expression; Humans; Immunohistochemistry; Lymphocyte Activation; Macrophage Inflammatory Proteins; Macrophages, Alveolar; Male; Middle Aged; Receptors, CCR6; Receptors, Chemokine; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sarcoidosis, Pulmonary; Severity of Illness Index; T-Lymphocytes | 2003 |
Prevention of progression of interstitial lung lesions by early combination therapy with corticosteroids and cyclosporine/cyclophosphamide in two patients with amyopathic dermatomyositis.
Topics: Adrenal Cortex Hormones; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Humans; Lung Diseases, Interstitial; Male; Middle Aged | 2002 |
Follow-up of patients with progressive multiple myeloma undergoing allografts after reduced-intensity conditioning.
Topics: Acute Disease; Adult; Aged; Antibiotics, Antineoplastic; Chronic Disease; Cyclosporine; Disease Progression; Disease-Free Survival; Drug Therapy, Combination; Female; Follow-Up Studies; Graft vs Host Disease; Humans; Immunosuppressive Agents; Male; Methylprednisolone; Middle Aged; Multiple Myeloma; Mycophenolic Acid; Stem Cell Transplantation; Survival Rate; Transplantation Conditioning; Transplantation, Homologous | 2003 |
A novel nitric oxide scavenger in combination with cyclosporine A ameliorates experimental autoimmune encephalomyelitis progression in mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Cyclosporine; Cytokines; Disease Progression; Drug Therapy, Combination; Encephalomyelitis, Autoimmune, Experimental; Enzyme Induction; Female; Free Radical Scavengers; Immunosuppressive Agents; Injections, Subcutaneous; Mice; Mice, Inbred Strains; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Organometallic Compounds; RNA, Messenger; Thiocarbamates; Up-Regulation | 2003 |
[Pyoderma gangrenosum and orbital pseudotumor].
Topics: Aged; Anti-Bacterial Agents; Biopsy; Cyclosporine; Disease Progression; Doxycycline; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Orbit; Orbital Pseudotumor; Postoperative Complications; Prednisolone; Pyoderma Gangrenosum; Recurrence; Scalp; Skin; Wound Healing | 2003 |
Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis.
Topics: Adult; Anti-Inflammatory Agents; Cardiovascular Diseases; Cohort Studies; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hypercholesterolemia; Hypertriglyceridemia; Immunosuppressive Agents; Incidence; Kidney Transplantation; Male; Middle Aged; Prednisolone; Prognosis; Retrospective Studies; Risk Factors; Severity of Illness Index; Sirolimus | 2003 |
Oral pemphigus vulgaris associated with HIV infection.
Topics: Adult; Antiretroviral Therapy, Highly Active; Cyclosporine; Disease Progression; HIV Infections; Humans; Immunosuppressive Agents; Male; Pemphigus | 2003 |
Autoimmune cardiomyopathy and heart block develop spontaneously in HLA-DQ8 transgenic IAbeta knockout NOD mice.
Topics: Animals; Autoimmune Diseases; Blotting, Western; Cardiomyopathies; Cell Division; Cyclosporine; Disease Progression; Electrocardiography; Enzyme-Linked Immunosorbent Assay; Freund's Adjuvant; Heart Block; HLA-DQ Antigens; Immunohistochemistry; Mice; Mice, Inbred NOD; Mice, Knockout; Mice, Transgenic; Myocardium; Spleen; T-Lymphocytes; Time Factors | 2003 |
Rapamycin inhibits the growth and metastatic progression of non-small cell lung cancer.
Topics: Adenocarcinoma; Animals; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Immunosuppressive Agents; In Vitro Techniques; Lung Neoplasms; Male; Mice; Mice, Inbred DBA; Sirolimus; Tumor Cells, Cultured | 2004 |
Ten-year radiographic outcome in patients with rheumatoid factor positive rheumatoid arthritis treated with aggressive immunosuppressive combination therapy.
Topics: Administration, Oral; Adolescent; Adult; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunosuppressive Agents; Infusions, Intravenous; Male; Methotrexate; Methylprednisolone; Middle Aged; Mycophenolic Acid; Prospective Studies; Pulse Therapy, Drug; Radiography; Remission Induction; Rheumatoid Factor; Treatment Outcome | 2004 |
[Recurrent polychondritis: apropos of a case].
Topics: Aspirin; Autoimmune Diseases; Azathioprine; Biopsy; Carcinoma, Squamous Cell; Conjunctivitis; Cyclosporine; Diagnosis, Differential; Disease Progression; Drug Therapy, Combination; Facial Neoplasms; Female; Fever; Hearing Disorders; Humans; Immunosuppressive Agents; Middle Aged; Nasal Obstruction; Otitis Media with Effusion; Polychondritis, Relapsing; Prednisone; Scleritis | 2003 |
Rapid steroid withdrawal in hepatitis C virus-positive kidney transplant recipients.
Topics: Adult; Aged; Antibodies, Monoclonal; Basiliximab; Cyclosporine; Disease Progression; Drug Therapy, Combination; Emulsions; Female; Glucocorticoids; Hepatitis C; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Function Tests; Male; Middle Aged; Mycophenolic Acid; Prednisolone; Prospective Studies; Recombinant Fusion Proteins; Tacrolimus; Treatment Outcome | 2004 |
Non-Hodgkin's lymphoma following treatment of atopic eczema with cyclosporin A.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chronic Disease; Cyclophosphamide; Cyclosporine; Dermatitis, Atopic; Disease Progression; Doxorubicin; Fatal Outcome; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Neoplasm Staging; Prednisolone; Severity of Illness Index; Vincristine | 2004 |
Long term follow-up of birdshot chorioretinopathy.
Topics: Adrenal Cortex Hormones; Chorioretinitis; Cyclosporine; Disease Progression; Drug Administration Schedule; Electrooculography; Electroretinography; Female; Fluorescein Angiography; Follow-Up Studies; Humans; Middle Aged; Prednisone; Scotoma; Treatment Outcome; Visual Acuity | 2004 |
Effect of tacrolimus in a patient with pure red-cell aplasia.
Topics: Aged; Anemia; Cyclosporine; Disease Progression; Erythrocyte Transfusion; Female; Humans; Kidney; Myasthenia Gravis; Red-Cell Aplasia, Pure; Remission Induction; Tacrolimus; Thymoma | 2005 |
Development of ulcerative colitis after heart transplantation during immunosuppressive therapy.
Topics: Biopsy; Colectomy; Colitis, Ulcerative; Colonoscopy; Cyclosporine; Disease Progression; Heart Failure; Heart Transplantation; Humans; Ileostomy; Immunosuppressive Agents; Intestinal Mucosa; Long-Term Care; Male; Middle Aged; Polymerase Chain Reaction; Postoperative Complications; Predictive Value of Tests; Prednisolone; Recurrence; Reoperation | 2005 |
Combining PUVA therapy with systemic immunosuppression to treat progressive diffuse morphoea.
Topics: Adult; Combined Modality Therapy; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Male; Mycophenolic Acid; PUVA Therapy; Scleroderma, Localized | 2005 |
Impact of immunosuppressive treatment on liver fibrosis in autoimmune hepatitis.
Topics: Adolescent; Adult; Analysis of Variance; Child; Cohort Studies; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Hepatitis, Autoimmune; Humans; Immunosuppressive Agents; Liver Cirrhosis; Liver Function Tests; Logistic Models; Male; Prednisolone; Probability; Retrospective Studies; Risk Assessment; Statistics, Nonparametric; Treatment Outcome | 2005 |
Long-term follow-up of patients with birdshot retinochoroidopathy treated with corticosteroid-sparing systemic immunomodulatory therapy.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Azathioprine; Choroid Diseases; Cyclosporine; Daclizumab; Disease Progression; Drug Therapy, Combination; Electroretinography; Female; Follow-Up Studies; HLA-A Antigens; Humans; Immunoglobulin G; Immunosuppressive Agents; Male; Methotrexate; Middle Aged; Mycophenolic Acid; Retinal Diseases; Retrospective Studies; Treatment Outcome; Visual Acuity | 2005 |
The natural history of renal function following orthotopic heart transplant.
Topics: Adult; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Heart Transplantation; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Male; Prognosis; Retrospective Studies; Risk Factors; Time Factors; Transplantation, Homologous | 2005 |
Long-term effects of cyclosporine in children with idiopathic nephrotic syndrome: a single-centre experience.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Glucocorticoids; Humans; Immunosuppressive Agents; Infant; Male; Nephrotic Syndrome; Prednisolone; Remission Induction; Retrospective Studies; Time Factors; Treatment Outcome | 2005 |
CNS involvement occurs more frequently in patients with Behçet's disease under cyclosporin A (CSA) than under other medications--results of a retrospective analysis of 117 cases.
Topics: Adolescent; Adult; Autonomic Nervous System Diseases; Azathioprine; Behcet Syndrome; Cohort Studies; Comorbidity; Cyclosporine; Disease Progression; Eye Diseases; Female; Germany; Humans; Immunosuppressive Agents; Incidence; Interferon-alpha; Male; Middle Aged; Prevalence; Retrospective Studies; Severity of Illness Index | 2006 |
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors.
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease Progression; Disease-Free Survival; Female; Follow-Up Studies; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Incidence; Leukemia, Myeloid, Acute; Living Donors; Male; Middle Aged; Mycophenolic Acid; Radiotherapy Dosage; Survival Analysis; Time Factors; Transplantation Conditioning; Treatment Outcome; Whole-Body Irradiation | 2006 |
Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis.
Topics: Animals; Collagen; Cyclosporine; Disease Models, Animal; Disease Progression; Dose-Response Relationship, Drug; Drug Combinations; Fibroblast Growth Factor 1; Follow-Up Studies; Heparin; Immunosuppressive Agents; Injections, Subcutaneous; Laminin; Mice; Mice, Inbred C3H; Neovascularization, Pathologic; Proteoglycans; Skin; Vascular Endothelial Growth Factor A | 2005 |
Early assessment of rapidly progressive interstitial pneumonia associated with amyopathic dermatomyositis.
Topics: Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Humans; Immunization, Passive; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Mediastinal Emphysema; Prognosis; Tomography, X-Ray Computed | 2007 |
The challenge of progressive hepatitis C following liver transplantation.
Topics: Cyclosporine; Disease Progression; Graft Rejection; Graft Survival; Hepacivirus; Hepatitis C, Chronic; Humans; Immunosuppressive Agents; In Vitro Techniques; Liver Failure; Liver Transplantation; Postoperative Complications; Recurrence; Sensitivity and Specificity | 2006 |
Bulbar palsy in multiple myeloma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Boronic Acids; Bortezomib; Bulbar Palsy, Progressive; Combined Modality Therapy; Cranial Fossa, Posterior; Cranial Nerve Diseases; Cyclosporine; Dexamethasone; Disease Progression; Doxorubicin; Fatal Outcome; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Immunoglobulin Light Chains; Immunosuppressive Agents; Magnetic Resonance Imaging; Methylprednisolone; Middle Aged; Multiple Myeloma; Myeloma Proteins; Pneumonia, Aspiration; Pyrazines; Reflex, Abnormal; Transplantation, Homologous; Vincristine | 2005 |
Significant improvement in the outcome of HCV-infected transplant recipients by avoiding rapid steroid tapering and potent induction immunosuppression.
Topics: Adult; Aged; Biopsy; Cohort Studies; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Liver; Liver Transplantation; Male; Middle Aged; Prednisone; Recurrence; Severity of Illness Index; Steroids; Tacrolimus; Time Factors; Treatment Outcome | 2006 |
Pirfenidone and chronic progressive obliterative airway disease.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bronchiolitis Obliterans; Cyclosporine; Disease Models, Animal; Disease Progression; Drug Therapy, Combination; Immunosuppressive Agents; Mice; Proteins; Pyridones; Rats | 2006 |
The dynamism of cutaneous lupus erythematosus: mild discoid lupus erythematosus evolving into SLE with SCLE and treatment-resistant lupus panniculitis.
Topics: Antimalarials; Azathioprine; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Hydroxychloroquine; Immunosuppressive Agents; Lupus Erythematosus, Systemic; Methotrexate; Methylprednisolone; Middle Aged; Panniculitis, Lupus Erythematosus; Pulse Therapy, Drug; Tacrolimus; Treatment Failure | 2007 |
Atypical lymphoproliferation progressing into B-cell lymphoma in rheumatoid arthritis treated with different biological agents: clinical course and molecular characterization.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Autoimmune Diseases; Contraindications; Cyclosporine; Disease Progression; Disease Susceptibility; DNA, Neoplasm; Etanercept; Female; Gene Rearrangement, B-Lymphocyte, Heavy Chain; Gene Rearrangement, B-Lymphocyte, Light Chain; Genes, Immunoglobulin; Humans; Immunocompromised Host; Immunoglobulin G; Immunosuppressive Agents; Lymphoma, Large B-Cell, Diffuse; Lymphoproliferative Disorders; Methotrexate; Neoplasm Proteins; Receptors, Tumor Necrosis Factor; Rituximab; Tumor Necrosis Factor-alpha | 2006 |
Characteristics and long-term outcome of 15 episodes of systemic lupus erythematosus-associated hemophagocytic syndrome.
Topics: Adolescent; Adult; C-Reactive Protein; Child; Cyclophosphamide; Cyclosporine; Disease Progression; Episode of Care; Female; Humans; Intensive Care Units; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Male; Methylprednisolone; Prednisone; Prognosis; Retrospective Studies; Time Factors; Treatment Outcome | 2006 |
In vivo luminescent imaging of cyclosporin A-mediated cancer progression in rats.
Topics: Adenocarcinoma; Animals; Benzamides; Blotting, Western; Cell Adhesion; Cell Line, Tumor; Cell Movement; Colonic Neoplasms; Cyclosporine; Dioxoles; Disease Progression; Gene Expression Regulation, Neoplastic; Image Processing, Computer-Assisted; Killer Cells, Natural; Liver Neoplasms; Luminescence; Lymphatic Metastasis; Male; Neoplasm Metastasis; Rats; Rats, Inbred F344; Receptors, Chemokine; Reperfusion Injury; Reverse Transcriptase Polymerase Chain Reaction; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2006 |
Predictors of chronic kidney disease in long-term survivors of lung and heart-lung transplantation.
Topics: Creatinine; Cyclosporine; Disease Progression; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Kidney Failure, Chronic; Lung Transplantation; Male; Middle Aged; Prognosis; Retrospective Studies; Risk Factors; Survivors; Time Factors; Transplantation, Homologous | 2006 |
Molecular mechanisms of cyclosporin A inhibition of the cytokine-induced matrix metalloproteinase-9 in glomerular mesangial cells.
Topics: Animals; Cells, Cultured; Cyclosporine; Cytokines; Disease Progression; Enzyme Induction; Glomerular Mesangium; Humans; Immunosuppressive Agents; Interleukin-1beta; Kidney Diseases; Matrix Metalloproteinase 9; Matrix Metalloproteinase Inhibitors; Rats; Recombinant Proteins; Tacrolimus | 2007 |
A serological switching from anti-dsDNA to anti-Sm antibodies coincided with severe clinical manifestations of systemic lupus erythematosus (hemophagocytosis, profundus and psychosis).
Topics: Administration, Oral; Antibodies, Antinuclear; Antibody Specificity; Autoantibodies; Autoantigens; Cyclosporine; Disease Progression; DNA; Drug Therapy, Combination; Fever; Humans; Immunosuppressive Agents; Infusions, Intravenous; Interleukin-6; Lupus Erythematosus, Systemic; Lymphohistiocytosis, Hemophagocytic; Memory Disorders; Methylprednisolone; Prednisolone; Psychotic Disorders; Ribonucleoproteins, Small Nuclear; Skin; snRNP Core Proteins | 2007 |
Association of steroid and cyclosporin resistance in focal segmental glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Disease Progression; Drug Resistance, Multiple; Female; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Immunosuppressive Agents; Male; Nephrotic Syndrome; Prednisone; Remission Induction; Retrospective Studies; Serum Albumin | 2007 |
Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.
Topics: Antilymphocyte Serum; Blood Transfusion; Child; Combined Modality Therapy; Cyclosporine; Disease Progression; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Humans; Immunosuppressive Agents; Kaplan-Meier Estimate; Leukocyte Count; Myelodysplastic Syndromes; Prednisone; Prospective Studies; Recurrence; Remission Induction; Statistics, Nonparametric; T-Lymphocytes; Treatment Outcome | 2007 |
Recovery from acute renal failure predisposes hypertension and secondary renal disease in response to elevated sodium.
Topics: Acute Kidney Injury; Aging; Animals; Blood Pressure; Capillaries; Catecholamines; Creatinine; Cyclosporine; Diet; Disease Progression; Hypertension, Renal; Immunohistochemistry; Immunosuppressive Agents; Kidney Failure, Chronic; Kidney Glomerulus; Kidney Tubules; Male; Organ Size; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin; Sodium; Sodium, Dietary | 2007 |
Clinical features of familial adenomas polyps in Chinese and establishment of its immortal lymphocyte cell lines.
Topics: Adenomatous Polyposis Coli; Adenomatous Polyposis Coli Protein; Adult; Aged; Cell Line; China; Colorectal Neoplasms; Cyclosporine; Disease Progression; Enzyme Inhibitors; Female; Genotype; Humans; Lymphocytes; Male; Middle Aged; Mutation; Pedigree; Risk Factors | 2007 |
Control of cyclosporine A-induced tumor progression using 15-deoxyspergualin for rat cardiac transplantation.
Topics: Animals; Caspase 3; Caspase 7; Cell Proliferation; Colonic Neoplasms; Cyclosporine; Disease Progression; Graft Survival; Guanidines; Heart; Heart Transplantation; Immunosuppressive Agents; Liver; Liver Neoplasms; Luciferases; NF-kappa B; Rats; Rats, Inbred F344; Rats, Inbred Lew | 2007 |
Cyclosporin A response and dependence in children with acquired aplastic anaemia: a multicentre retrospective study with long-term observation follow-up.
Topics: Adolescent; Anemia, Aplastic; Child; Child, Preschool; Cyclosporine; Disease Progression; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Epidemiologic Methods; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunosuppressive Agents; Infant; Male; Recurrence; Treatment Outcome | 2008 |
Sirolimus conversion for renal preservation in liver transplantation: not so fast.
Topics: Antimetabolites; Calcineurin Inhibitors; Creatinine; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Renal Insufficiency, Chronic; Renal Replacement Therapy; Sirolimus; Tacrolimus; Treatment Outcome | 2008 |
Sirolimus in liver transplant recipients with renal dysfunction offers no advantage over low-dose calcineurin inhibitor regimens.
Topics: Adult; Aged; Antimetabolites; Calcineurin Inhibitors; Case-Control Studies; Creatinine; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Graft Rejection; Humans; Immunosuppressive Agents; Liver Diseases; Liver Transplantation; Male; Middle Aged; Renal Insufficiency, Chronic; Renal Replacement Therapy; Retrospective Studies; Sirolimus; Tacrolimus; Time Factors; Treatment Outcome | 2008 |
Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A.
Topics: Animals; Antineoplastic Agents; Cell Count; Cyclosporine; Disease Progression; Female; Immunosuppressive Agents; Incidence; Lymph Nodes; Mast Cells; Mice; Mice, Hairless; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Neutrophils; Sirolimus; Skin; Skin Neoplasms; Transforming Growth Factor beta1; Tumor Burden; Ultraviolet Rays | 2008 |
Prevalence and clinical course of hepatitis B and hepatitis C liver disease in ciclosporin-treated renal allograft recipients.
Topics: Adult; Chronic Disease; Cyclosporine; Disease Progression; Female; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis C; Hepatitis C Antibodies; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Prevalence; Retrospective Studies; Survival Rate; Transplantation, Homologous | 1995 |
New perspectives on treating rheumatoid arthritis.
Topics: Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Drug Therapy, Combination; Humans; Methotrexate; Prednisolone | 1995 |
A rapidly progressing leiomyosarcoma expressing drug-resistance markers failed to respond to cyclosporin A-associated chemotherapy.
Topics: Adult; Cyclosporine; Disease Progression; Drug Resistance, Multiple; Female; Humans; Leiomyosarcoma | 1994 |
The use of cyclosporin-A in the treatment of B-chronic lymphocytic leukemia.
Topics: Anemia, Hemolytic, Autoimmune; Autoimmune Diseases; Cyclosporine; Disease Progression; Drug Resistance; Fatal Outcome; Female; Hemoglobins; Humans; Interleukin-2; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, B-Cell; Middle Aged; Neoplastic Stem Cells; Recombinant Proteins | 1995 |
Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
Topics: Azathioprine; Biopsy; Cyclosporine; Disease Progression; Endocardium; Female; Graft Rejection; Heart Transplantation; Humans; Immunosuppression Therapy; Male; Middle Aged; Myocardium; Prednisone; Survival Analysis; Time Factors | 1995 |
Pure red cell aplasia: its clinical association and treatment.
Topics: Chromosome Aberrations; Clone Cells; Cyclophosphamide; Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Leukemia-Lymphoma, Adult T-Cell; Preleukemia; Red-Cell Aplasia, Pure; Treatment Outcome | 1996 |
Slow progression of joint damage in early rheumatoid arthritis treated with cyclosporin A or methotrexate: comment on the article by Pasero et al.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Cyclosporine; Disease Progression; Humans; Joint Diseases; Methotrexate | 1997 |
Vinorelbine therapy for Kaposi's sarcoma in a kidney transplant patient.
Topics: Antineoplastic Agents, Phytogenic; Azathioprine; Cyclosporine; Disease Progression; Follow-Up Studies; Humans; Immunosuppressive Agents; Kidney Transplantation; Lymphatic Metastasis; Male; Middle Aged; Remission Induction; Sarcoma, Kaposi; Skin Neoplasms; Vinblastine; Vinorelbine | 1997 |
Characterization of JC virus DNA amplified from urine of chronic progressive multiple sclerosis patients.
Topics: Adult; Amino Acid Sequence; Base Sequence; Case-Control Studies; Chronic Disease; Cyclosporine; Disease Progression; DNA, Viral; Female; Humans; Immunosuppressive Agents; JC Virus; Male; Middle Aged; Molecular Sequence Data; Multiple Sclerosis; Polymerase Chain Reaction | 1996 |
[Rheumatoid arthritis in children: modifying effect of cyclosporin A].
Topics: Adolescent; Antirheumatic Agents; Arthritis, Juvenile; Child; Child, Preschool; Cyclosporine; Disease Progression; Drug Administration Routes; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunologic Factors; Male; Prednisolone; Range of Motion, Articular; Treatment Outcome | 1998 |
Pulpal lesions in normal and cyclosporin A treated rats.
Topics: Animals; Cyclosporine; Dental Pulp; Dental Pulp Necrosis; Disease Progression; Immunosuppressive Agents; Male; Rats; Rats, Wistar; Time Factors | 1997 |
The relationship between serum-soluble interleukin-2 receptor and radiological evolution in psoriatic arthritis patients treated with cyclosporin-A.
Topics: Administration, Oral; Arthritis, Psoriatic; Biomarkers; Cyclosporine; Disease Progression; Enzyme-Linked Immunosorbent Assay; Female; Finger Joint; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Prognosis; Prospective Studies; Radiography; Receptors, Interleukin-2; Tarsal Joints | 1998 |
Potential role of computerized visual field testing for the appraisal and follow-up of birdshot chorioretinopathy.
Topics: Adult; Chorioretinitis; Cyclosporine; Disease Progression; Drug Therapy, Combination; Fluorescein Angiography; Follow-Up Studies; Fundus Oculi; Humans; Male; Prednisone; Visual Field Tests; Visual Fields | 1998 |
Drug-combination therapy of rheumatoid arthritis.
Topics: Antirheumatic Agents; Arthritis, Rheumatoid; Biopsy; Cyclophosphamide; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Fluocortolone; Glucocorticoids; Humans; Kidney; Longitudinal Studies; Male; Methotrexate; Middle Aged | 1998 |
Posterior leukoencephalopathy syndrome may not be reversible.
Topics: Bone Marrow Transplantation; Brain Diseases; Child, Preschool; Chromosomes, Human, Pair 7; Cyclosporine; Disease Progression; Humans; Hypertension, Malignant; Leukemia, Myeloid, Acute; Magnetic Resonance Imaging; Male; Monosomy; Myelodysplastic Syndromes; Occipital Lobe; Ocular Motility Disorders; Syndrome; Tomography, X-Ray Computed | 1999 |
Unusual clinical presentation in a patient with myelodysplastic syndrome, with subsequent hematological remission and suppression of the malignant clone following treatment with cyclosporine A, erythropoietin and granulocyte colony-stimulating factor.
Topics: Adult; Autoimmune Diseases; Cyclosporine; Disease Progression; Drug Therapy, Combination; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Humans; Myelodysplastic Syndromes; Platelet Count; Remission Induction; Thrombocytopenia | 1999 |
Postinjury cyclosporin A administration limits axonal damage and disconnection in traumatic brain injury.
Topics: Amyloid beta-Protein Precursor; Animals; Axons; Biomarkers; Brain Injuries; Brain Stem; Calcium; Calpain; Cyclosporine; Disease Models, Animal; Disease Progression; Male; Neural Pathways; Neurofilament Proteins; Neuroprotective Agents; Rats; Rats, Sprague-Dawley; Spectrin | 1999 |
Cerebrospinal fluid somatostatin, mood, and cognition in multiple sclerosis.
Topics: Adult; Affect; Analysis of Variance; Case-Control Studies; Chronic Disease; Clinical Trials as Topic; Cognition; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Multiple Sclerosis; Neuropsychological Tests; Somatostatin; Time Factors | 1999 |
FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation.
Topics: Animals; Coronary Artery Disease; Cyclosporine; Disease Progression; Fingolimod Hydrochloride; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Interferon-gamma; Interleukin-2; Male; Mice; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred DBA; Postoperative Complications; Propylene Glycols; Sphingosine; T-Lymphocytes, Cytotoxic | 1999 |
Effect of diacerein on spontaneous polyarthritis in male New Zealand black/KN mice.
Topics: Animals; Anthraquinones; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Cyclosporine; Disease Progression; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred NZB; Radiography | 1999 |
The relative influence of antigen-dependent and independent factors for development and progression of chronic rejection.
Topics: Acute Disease; Animals; Aorta; Chronic Disease; Cyclosporine; Disease Progression; Graft Rejection; Heart Transplantation; Isoantigens; Rats; Transplantation, Homologous | 1999 |
Calcineurin expression, activation, and function in cardiac pressure-overload hypertrophy.
Topics: Animals; Calcineurin; Calcineurin Inhibitors; Cardiomegaly; Cyclosporine; Disease Progression; Female; Hypertension; Immunosuppressive Agents; Rats; Rats, Sprague-Dawley | 2000 |
Cardiac calcineurin during transition from hypertrophy to heart failure in rats.
Topics: Adaptation, Physiological; Angiotensin-Converting Enzyme Inhibitors; Animals; Blotting, Western; Body Weight; Calcineurin; Calcineurin Inhibitors; Cyclosporine; Disease Progression; Down-Regulation; Electrocardiography; Heart Failure; Hemodynamics; Hypertension; Hypertrophy; Myocardium; Rats; Rats, Inbred Dahl; Thiazepines | 2000 |
[Index of histopathological changes in rapidly progressive glomerulonephritis: a preliminary report].
Topics: Anti-Inflammatory Agents; Antimetabolites, Antineoplastic; Azathioprine; Biopsy; Child; Chronic Disease; Cyclosporine; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Enzyme Inhibitors; Female; Glomerulonephritis; Humans; Kidney; Prednisone; Prognosis; Remission, Spontaneous; Severity of Illness Index | 2000 |
Cyclosporin A reverses chemoresistance in patients with gynecologic malignancies.
Topics: Choriocarcinoma; Cyclosporine; Disease Progression; Drug Resistance, Multiple; Female; Genital Neoplasms, Female; Humans; Immunosuppressive Agents; Middle Aged; Ovarian Neoplasms; Time Factors; Treatment Outcome; Uterine Cervical Neoplasms; Uterine Neoplasms | 1999 |
Hepatitis C after liver transplantation.
Topics: Cyclosporine; Disease Progression; Drug Therapy, Combination; Hepatitis C; Humans; Immunosuppressive Agents; Liver Failure; Liver Transplantation; Prognosis; Recurrence; Renal Insufficiency; Risk Factors; Sepsis; Tacrolimus; Treatment Outcome | 2000 |
Successful use of cyclosporin A in progressive anti-glomerular basement membrane nephritis.
Topics: Anti-Glomerular Basement Membrane Disease; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Middle Aged | 2000 |
Efficacies of sirolimus (rapamycin) and cyclosporine in allograft vascular disease in non-human primates: trough levels of sirolimus correlate with inhibition of progression of arterial intimal thickening.
Topics: Animals; Aorta; Cyclosporine; Disease Progression; Immunosuppressive Agents; Macaca fascicularis; Male; Regression Analysis; Sirolimus; Transplantation, Homologous; Tunica Intima | 2000 |
Acute rejection and the therapeutic choice of drug.
Topics: Acute Disease; Adult; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; Graft Rejection; Graft Survival; Guanidines; Histocompatibility Testing; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Muromonab-CD3; Retrospective Studies; Tacrolimus; Time Factors; Treatment Outcome | 2000 |
Conservation of small-airway function by tacrolimus/cyclosporine conversion in the management of bronchiolitis obliterans following lung transplantation.
Topics: Biopsy; Bronchi; Bronchiolitis Obliterans; Cyclosporine; Disease Progression; Follow-Up Studies; Forced Expiratory Volume; Heart-Lung Transplantation; Humans; Immunosuppressive Agents; Lung Transplantation; Maximal Midexpiratory Flow Rate; Retrospective Studies; Spirometry; Statistics, Nonparametric; Syndrome; Tacrolimus | 2000 |
Remitting asymmetrical pitting oedema in systemic lupus erythematosus: two cases studied with magnetic resonance imaging.
Topics: Adult; Ankle; Cyclosporine; Disease Progression; Drug Therapy, Combination; Edema; Female; Functional Laterality; Humans; Lupus Erythematosus, Systemic; Magnetic Resonance Imaging; Methotrexate; Prednisone; Remission, Spontaneous; Treatment Outcome; Wrist | 2000 |
[A case of Sjögren's syndrome with dermatomyositis who died of rapidly progressive interstitial pneumonia].
Topics: Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Fatal Outcome; Female; Humans; Lung Diseases, Interstitial; Methylprednisolone; Middle Aged; Prednisolone; Pulse Therapy, Drug; Sjogren's Syndrome | 2001 |
Autoimmune-mediated vasculopathy.
Topics: Adoptive Transfer; Animals; Antigens, Differentiation, B-Lymphocyte; Arteriosclerosis; Autoimmune Diseases; Chloroquine; Cyclosporine; Cytotoxicity, Immunologic; Disease Progression; Female; Graft Rejection; Graft vs Host Disease; Heart Transplantation; Histocompatibility Antigens Class II; Immunosuppressive Agents; Lymphocyte Depletion; Lymphokines; Macromolecular Substances; Postoperative Complications; Radiation Chimera; Rats; Rats, Inbred Lew; T-Lymphocytes; Th1 Cells; Th2 Cells; Thymectomy; Transplantation, Isogeneic; Tunica Intima; Tunica Media; Vasculitis | 2001 |
Immunosuppressive therapy in serpiginous choroiditis--case report and brief review of the literature.
Topics: Adult; Azathioprine; Choroiditis; Cyclosporine; Disease Progression; Drug Therapy, Combination; Fluorescein Angiography; Humans; Immunosuppressive Agents; Male; Prednisone; Visual Fields | 2001 |
What is proper treatment for Wegener granulomatosis?
Topics: Adult; Cyclophosphamide; Cyclosporine; Cystitis; Disease Progression; Female; Granulomatosis with Polyangiitis; Humans; Immunosuppressive Agents; Neural Tube Defects; Recurrence; Treatment Refusal; Urinary Bladder Neoplasms | 2001 |
Prodigiosin blocks T cell activation by inhibiting interleukin-2Ralpha expression and delays progression of autoimmune diabetes and collagen-induced arthritis.
Topics: Animals; Anti-Bacterial Agents; Antirheumatic Agents; Arthritis; Cell Division; Collagen; Cyclosporine; Cytokines; Diabetes Mellitus, Type 1; Disease Progression; Female; Gene Expression Regulation; Interleukin-2; Interleukin-2 Receptor alpha Subunit; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Nitrites; Prodigiosin; Receptors, Interleukin; Signal Transduction; T-Lymphocytes | 2001 |
Oral cyclosporin does not arrest progression of androgenetic alopecia.
Topics: Administration, Oral; Adult; Alopecia; Cyclosporine; Dermatologic Agents; Disease Progression; Drug Eruptions; Humans; Hypertrichosis; Male; Psoriasis | 2001 |
Renal involvement after lung transplantation for sarcoidosis.
Topics: Cyclosporine; Disease Progression; Humans; Immunosuppressive Agents; Kidney; Kidney Failure, Chronic; Lung Transplantation; Male; Middle Aged; Sarcoidosis, Pulmonary | 2001 |
Successful treatment of a case with rapidly progressive Bronchiolitis obliterans organizing pneumonia (BOOP) using cyclosporin A and corticosteroid.
Topics: Anti-Inflammatory Agents; Cryptogenic Organizing Pneumonia; Cyclosporine; Disease Progression; Drug Therapy, Combination; Female; Humans; Middle Aged; Prednisolone; Treatment Outcome | 2002 |
Early cyclosporine a withdrawal in kidney transplant recipients under a sirolimus-based immunosuppressive regimen: pathological study of graft biopsies at 1-year posttransplant.
Topics: Biopsy; Cyclosporine; Disease Progression; Drug Therapy, Combination; Graft Survival; Humans; Immunosuppressive Agents; Kidney Transplantation; Sirolimus; Time Factors; Treatment Outcome | 2002 |
Successful treatment of progressive rheumatoid interstitial lung disease with cyclosporine: a case report.
Topics: Anti-Inflammatory Agents; Antirheumatic Agents; Arthritis, Rheumatoid; Cyclophosphamide; Cyclosporine; Disease Progression; Female; Glucocorticoids; Humans; Lung Diseases, Interstitial; Middle Aged; Prednisolone; Radiography; Treatment Outcome | 2002 |
Reversible acceleration of disease progression following cyclosporin A treatment in a patient with myelodysplastic syndrome.
Topics: Adult; Anemia, Refractory, with Excess of Blasts; Asian People; Blood Cell Count; Bone Marrow; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Japan; Myelodysplastic Syndromes; Treatment Outcome | 2002 |
[Treatment of myelodysplastic syndromes with immunosuppressive agents].
Topics: Adolescent; Adult; Aged; Cyclosporine; Disease Progression; Female; Humans; Immunosuppressive Agents; Male; Middle Aged; Myelodysplastic Syndromes; Retrospective Studies | 2002 |
Usefulness of cyclosporine A on rapidly progressive interstitial pneumonia in dermatomyositis.
Topics: Adult; Cyclophosphamide; Cyclosporine; Dermatomyositis; Disease Progression; Drug Therapy, Combination; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Lung Diseases, Interstitial; Male; Methylprednisolone; Middle Aged; Prednisolone; Retrospective Studies; Treatment Outcome | 2002 |